Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
EPHB2	2048	broad.mit.edu	37	1	23110979	23110979	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr1:23110979G>A	ENST00000400191.3	+	3	239	c.221G>A	c.(220-222)cGg>cAg	p.R74Q	EPHB2_ENST00000374627.1_Missense_Mutation_p.R68Q|EPHB2_ENST00000374630.3_Missense_Mutation_p.R74Q|EPHB2_ENST00000544305.1_Missense_Mutation_p.R74Q|EPHB2_ENST00000374632.3_Missense_Mutation_p.R74Q	NM_004442.6|NM_017449.3	NP_004433.2|NP_059145.2	P29323	EPHB2_HUMAN	EPH receptor B2	74		NA			axon guidance	integral to plasma membrane	ATP binding|transmembrane-ephrin receptor activity			NS(1)|breast(1)|endometrium(6)|kidney(2)|large_intestine(10)|lung(17)|ovary(4)|pancreas(2)|prostate(3)|skin(8)|stomach(1)|urinary_tract(1)	56		Colorectal(325;3.46e-05)|Lung NSC(340;3.7e-05)|all_lung(284;5.45e-05)|Renal(390;0.000228)|Breast(348;0.0027)|Ovarian(437;0.00327)|Myeloproliferative disorder(586;0.0258)		UCEC - Uterine corpus endometrioid carcinoma (279;0.0348)|OV - Ovarian serous cystadenocarcinoma(117;3.67e-26)|Colorectal(126;3.23e-08)|COAD - Colon adenocarcinoma(152;9.32e-07)|GBM - Glioblastoma multiforme(114;2.93e-05)|BRCA - Breast invasive adenocarcinoma(304;0.000606)|KIRC - Kidney renal clear cell carcinoma(1967;0.00371)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.126)|Lung(427;0.153)		AACTGGCTACGGACCAAGTTT	0.587		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													74	66	69			NA	NA	1		NA											NA				23110979		2203	4300	6503	SO:0001583	missense			ENSG00000133216	HGNC:3393	NM_017449	Approved	uc001bge.3	NA	O43477|Q5T0U6|Q5T0U7|Q5T0U8	ENST00000400191.3	37		.	.	.	.	.	.	.	.	.	.	G	22.2	4.254964	0.80135	.	.	ENSG00000133216	ENST00000374625;ENST00000544305;ENST00000374630;ENST00000400191;ENST00000374632;ENST00000374627	T;T;T;T;T	0.11385	2.78;2.78;2.78;2.78;2.78	5.19	5.19	0.71726	Ephrin receptor, ligand binding (2);Galactose-binding domain-like (1);	0.000000	0.85682	D	0.000000	T	0.27169	0.0666	M	0.65320	2	0.58432	D	0.999998	D;D;D;P	0.76494	0.985;0.999;0.999;0.556	P;D;D;B	0.68039	0.672;0.955;0.955;0.131	T	0.00131	-1.2013	10	0.45353	T	0.12	.	12.5128	0.56015	0.0:0.0:0.8331:0.1669	.	74;74;92;74	A6NJM0;P29323;Q4LE53;P29323-3	.;EPHB2_HUMAN;.;.	Q	74;74;74;74;74;68	ENSP00000444174:R74Q;ENSP00000363761:R74Q;ENSP00000383053:R74Q;ENSP00000363763:R74Q;ENSP00000363758:R68Q	ENSP00000363755:R74Q	R	+	2	0	EPHB2	22983566	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	7.593000	0.82686	2.704000	0.92352	0.484000	0.47621	CGG	EPHB2-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000008060.2	75.275025	KEEP		+	75.291754	0.478261	22	24	---	---	---	---	1	1	60	54	0	46	24	30	0	46	2	0	0	0	0	0	0	24	30	0	46	2	TP
CCDC18	343099	broad.mit.edu	37	1	93649533	93649533	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr1:93649533A>T	ENST00000343253.7	+	3	636		c.e3-1		CCDC18_ENST00000557479.1_Splice_Site|CCDC18_ENST00000334652.5_Splice_Site|CCDC18_ENST00000401026.3_Splice_Site|CCDC18_ENST00000338949.4_Splice_Site			Q5T9S5	CCD18_HUMAN	coiled-coil domain containing 18	NA		NA								breast(5)|endometrium(3)|kidney(1)|large_intestine(6)|lung(19)|ovary(3)|pancreas(1)|upper_aerodigestive_tract(1)|urinary_tract(3)	42		all_lung(203;0.00196)|Lung NSC(277;0.00903)|Melanoma(281;0.099)|all_neural(321;0.185)|Glioma(108;0.203)		all cancers(265;0.00166)|GBM - Glioblastoma multiforme(16;0.00551)|Epithelial(280;0.0967)		TTTTTTCTCTAGTGTTAGTCC	0.328		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													115	105	108			NA	NA	1		NA											NA				93649533		1810	4073	5883	SO:0001630	splice_region_variant			ENSG00000122483	HGNC:30370	NM_206886	Approved	uc021opx.1	NA	Q6ZU17	ENST00000343253.7	37		.	.	.	.	.	.	.	.	.	.	A	19.31	3.803472	0.70682	.	.	ENSG00000122483	ENST00000343253;ENST00000401026;ENST00000557479;ENST00000448243;ENST00000370276	.	.	.	6.02	6.02	0.97574	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.9043	0.63823	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	CCDC18	93422121	1.000000	0.71417	1.000000	0.80357	0.918000	0.54935	2.947000	0.49058	2.306000	0.77630	0.482000	0.46254	.	CCDC18-008	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000382327.1	-32.973023	KEEP	Intron	+	11.547633	0.040816	8	188	---	---	---	---	1	0.008640907	3	1	0	254	8	232	0	254	2	0	0	0	0	0	0	8	232	0	254	2	TP
CDC14A	8556	broad.mit.edu	37	1	100843100	100843100	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr1:100843100A>T	ENST00000370125.2	+	3	628		c.e3-1		AC104457.1_ENST00000401248.1_RNA|CDC14A_ENST00000361544.6_Splice_Site|CDC14A_ENST00000336454.3_Splice_Site|CDC14A_ENST00000544534.1_Splice_Site|CDC14A_ENST00000542213.1_Splice_Site|CDC14A_ENST00000370124.3_Splice_Site			Q9UNH5	CC14A_HUMAN	cell division cycle 14A	NA		NA			cell cycle|cell division|cell proliferation	centrosome|nucleus|spindle	protein binding|protein tyrosine phosphatase activity|protein tyrosine/serine/threonine phosphatase activity			breast(1)|endometrium(5)|kidney(6)|large_intestine(6)|lung(10)|skin(2)|urinary_tract(1)	31		all_epithelial(167;3.71e-06)|all_lung(203;0.00097)|Lung NSC(277;0.001)		Epithelial(280;0.0676)|all cancers(265;0.127)|COAD - Colon adenocarcinoma(174;0.201)|Lung(183;0.227)|Colorectal(144;0.241)		CTTGTATCTTAGTTTCTATGC	0.279		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													79	75	76			NA	NA	1		NA											NA				100843100		2203	4299	6502	SO:0001630	splice_region_variant			ENSG00000079335	HGNC:1718	NM_033312	Approved	uc001dtf.2	NA	B1AQ14|B1AQ15|O43171|O60727|O60728|Q8IXX0	ENST00000370125.2	37		.	.	.	.	.	.	.	.	.	.	A	21.3	4.130672	0.77549	.	.	ENSG00000079335	ENST00000455467;ENST00000370125;ENST00000361544;ENST00000370124;ENST00000336454;ENST00000544534	.	.	.	5.64	5.64	0.86602	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.832	0.70156	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	CDC14A	100615688	1.000000	0.71417	0.997000	0.53966	0.888000	0.51559	8.378000	0.90144	2.149000	0.67028	0.374000	0.22700	.	CDC14A-201	KNOWN	basic	protein_coding	NA	protein_coding		-15.884185	KEEP	Intron	+	8.371573	0.045455	5	105	---	---	---	---	1	0.03001846	5	0	0	132	7	134	0	132	2	0	0	0	0	0	0	7	134	0	132	2	TP
SLC30A7	148867	broad.mit.edu	37	1	101427382	101427382	+	Splice_Site	SNP	A	A	T	rs5776552		GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr1:101427382A>T	ENST00000370112.4	+	9	1029		c.e9-1		SLC30A7_ENST00000357650.4_Splice_Site	NM_001144884.1|NM_133496.4	NP_001138356.1|NP_598003.2	Q8NEW0	ZNT7_HUMAN	solute carrier family 30 (zinc transporter), member 7	NA		NA			zinc ion transport	Golgi apparatus|integral to membrane	cation transmembrane transporter activity|protein binding			endometrium(3)|large_intestine(2)|lung(10)	15		all_epithelial(167;0.000445)|all_lung(203;0.00645)|Lung NSC(277;0.0119)		Epithelial(280;0.0437)|all cancers(265;0.0498)|COAD - Colon adenocarcinoma(174;0.162)|Colorectal(144;0.19)|Lung(183;0.201)		CCTTTTCCTTAGTGTTATTCC	0.368		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(91;473 1491 3102 16827 21633)							NA		NA		0													155	159	157			NA	NA	1		NA											NA				101427382		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000162695	HGNC:19306	NM_133496	Approved	uc001dto.2	NA	B2R949|D3DT61|Q8TCH2	ENST00000370112.4	37	CCDS776.1	.	.	.	.	.	.	.	.	.	.	A	18.98	3.738797	0.69304	.	.	ENSG00000162695	ENST00000370112;ENST00000357650	.	.	.	5.47	5.47	0.80525	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.5419	0.76057	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SLC30A7	101199970	1.000000	0.71417	0.934000	0.37439	0.970000	0.65996	8.746000	0.91604	2.072000	0.62099	0.528000	0.53228	.	SLC30A7-001	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000032711.1	-19.728891	KEEP	Intron	+	7.66514	0.041322	5	116	---	---	---	---	1	0.07317013	11	0	0	270	5	145	0	270	2	0	0	0	0	0	0	5	145	0	270	2	TP
SOAT1	6646	broad.mit.edu	37	1	179319429	179319429	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr1:179319429A>T	ENST00000367619.3	+	14	1457		c.e14-1		SOAT1_ENST00000539888.1_Splice_Site|SOAT1_ENST00000535686.1_Splice_Site|SOAT1_ENST00000540564.1_Splice_Site	NM_003101.5	NP_003092.4	P35610	SOAT1_HUMAN	sterol O-acyltransferase 1	NA		NA			cholesterol efflux|cholesterol esterification|cholesterol homeostasis|cholesterol metabolic process|cholesterol storage|macrophage derived foam cell differentiation|positive regulation of amyloid precursor protein biosynthetic process|very-low-density lipoprotein particle assembly	endoplasmic reticulum membrane|integral to membrane|microsome	cholesterol binding|cholesterol O-acyltransferase activity|fatty-acyl-CoA binding			central_nervous_system(1)|endometrium(3)|large_intestine(1)|lung(10)|prostate(1)|skin(3)|stomach(1)	20					Ezetimibe(DB00973)|Hesperetin(DB01094)	CTTTTTCTTTAGTTTTTCTCC	0.333		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													122	112	115			NA	NA	1		NA											NA				179319429		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000057252	HGNC:11177	NM_003101	Approved	uc001gml.3	NA	A6NC40|A9Z1V7|Q5T0X4|Q8N1E4	ENST00000367619.3	37	CCDS1330.1	.	.	.	.	.	.	.	.	.	.	A	11.54	1.668872	0.29604	.	.	ENSG00000057252	ENST00000539888;ENST00000540564;ENST00000535686;ENST00000367619	.	.	.	5.51	4.32	0.51571	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.4654	0.44604	0.7419:0.2581:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SOAT1	177586052	1.000000	0.71417	0.901000	0.35422	0.560000	0.35617	5.599000	0.67592	2.217000	0.71921	0.482000	0.46254	.	SOAT1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000085286.2	-18.891533	KEEP	Intron	+	12.026137	0.048951	7	136	---	---	---	---	1	0.9069333	77	0	0	194	9	160	0	194	2	0	0	0	0	0	0	9	160	0	194	2	TP
RANBP2	5903	broad.mit.edu	37	2	109378555	109378555	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr2:109378555A>T	ENST00000283195.6	+	19	2728		c.e19-1			NM_006267.4	NP_006258.3	P49792	RBP2_HUMAN	RAN binding protein 2	NA		NA			carbohydrate metabolic process|glucose transport|mitotic prometaphase|mRNA transport|protein folding|protein import into nucleus|regulation of glucose transport|transmembrane transport|viral reproduction	cytosol|nuclear pore	peptidyl-prolyl cis-trans isomerase activity|Ran GTPase binding|zinc ion binding		RANBP2/ALK(34)	NS(1)|biliary_tract(1)|breast(3)|endometrium(13)|haematopoietic_and_lymphoid_tissue(1)|kidney(21)|large_intestine(19)|lung(51)|pancreas(1)|prostate(8)|skin(7)|upper_aerodigestive_tract(2)|urinary_tract(1)	129						TTGTTTTTTTAGTTGCAACTA	0.333		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													91	100	97			NA	NA	2		NA											NA				109378555		931	2027	2958	SO:0001630	splice_region_variant			ENSG00000153201	HGNC:9848	NM_006267	Approved	uc002tem.4	NA	Q13074|Q15280|Q53TE2|Q59FH7	ENST00000283195.6	37	CCDS2079.1	.	.	.	.	.	.	.	.	.	.	A	22.5	4.294558	0.81025	.	.	ENSG00000153201	ENST00000409491;ENST00000283195	.	.	.	5.22	5.22	0.72569	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.3858	0.74699	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	RANBP2	108744987	1.000000	0.71417	1.000000	0.80357	0.983000	0.72400	6.847000	0.75404	2.088000	0.63022	0.455000	0.32223	.	RANBP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253594.1	-20.905692	KEEP	Intron	+	6.749173	0.034188	4	113	---	---	---	---	1	0.06185748	9	1	0	221	5	145	0	221	2	0	0	0	0	0	0	5	145	0	221	2	TP
DCAF17	80067	broad.mit.edu	37	2	172314880	172314880	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr2:172314880A>T	ENST00000375255.3	+	8	1059		c.e8-1		DCAF17_ENST00000539783.1_Splice_Site|DCAF17_ENST00000468592.1_Intron	NM_025000.3	NP_079276.2	Q5H9S7	DCA17_HUMAN	DDB1 and CUL4 associated factor 17	NA		NA				CUL4 RING ubiquitin ligase complex|integral to membrane|nucleolus				endometrium(1)|kidney(2)|large_intestine(3)|lung(10)|prostate(1)	17						TTTTGTTTTTAGTTCATGCAA	0.358		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													94	89	91			NA	NA	2		NA											NA				172314880		1853	4098	5951	SO:0001630	splice_region_variant			ENSG00000115827	HGNC:25784	NM_025000	Approved	uc002ugx.3	NA	B2RTW5|Q53TN3|Q9H908	ENST00000375255.3	37	CCDS2243.2	.	.	.	.	.	.	.	.	.	.	A	20.4	3.984850	0.74474	.	.	ENSG00000115827	ENST00000375255;ENST00000539783	.	.	.	5.75	5.75	0.90469	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.6994	0.77533	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	DCAF17	172023126	1.000000	0.71417	1.000000	0.80357	0.997000	0.91878	6.803000	0.75180	2.192000	0.70111	0.477000	0.44152	.	DCAF17-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255342.2	-16.352689	KEEP	Intron	+	23.822443	0.067961	14	192	---	---	---	---	1	0.2661829	5	10	0	180	16	236	0	180	2	0	0	0	0	0	0	16	236	0	180	2	TP
ZNF804A	91752	broad.mit.edu	37	2	185802513	185802513	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr2:185802513G>A	ENST00000302277.6	+	4	2984	c.2390G>A	c.(2389-2391)aGg>aAg	p.R797K		NM_194250.1	NP_919226.1	Q7Z570	Z804A_HUMAN	zinc finger protein 804A	797		NA				intracellular	zinc ion binding			NS(5)|breast(2)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(7)|large_intestine(22)|liver(2)|lung(79)|ovary(7)|pancreas(1)|prostate(2)|skin(12)|urinary_tract(1)	146						GAATTTTTGAGGCCACCAAGT	0.383		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													47	52	50			NA	NA	2		NA											NA				185802513		2200	4299	6499	SO:0001583	missense			ENSG00000170396	HGNC:21711	NM_194250	Approved	uc002uph.3	NA	A7E253|Q6ZN26	ENST00000302277.6	37	CCDS2291.1	.	.	.	.	.	.	.	.	.	.	G	6.533	0.466662	0.12402	.	.	ENSG00000170396	ENST00000302277	T	0.05717	3.4	5.81	-0.729	0.11158	.	0.658159	0.14608	N	0.309201	T	0.04679	0.0127	L	0.33485	1.01	0.09310	N	1	B	0.21071	0.051	B	0.12156	0.007	T	0.37174	-0.9717	10	0.35671	T	0.21	-0.6984	7.3086	0.26461	0.1932:0.334:0.4727:0.0	.	797	Q7Z570	Z804A_HUMAN	K	797	ENSP00000303252:R797K	ENSP00000303252:R797K	R	+	2	0	ZNF804A	185510758	0.030000	0.19436	0.000000	0.03702	0.467000	0.32768	0.242000	0.18087	-0.127000	0.11661	0.655000	0.94253	AGG	ZNF804A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255871.1	130.348886	KEEP		+	133.24386	0.336066	41	81	---	---	---	---	1	0.7213794	2	5	1	108	45	93	1	108	2	0	0	0	0	0	0	45	93	1	108	2	TP
PIK3CA	5290	broad.mit.edu	37	3	178916921	178916921	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr3:178916921A>G	ENST00000263967.3	+	2	465	c.308A>G	c.(307-309)gAa>gGa	p.E103G		NM_006218.2	NP_006209.2	P42336	PK3CA_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit alpha	103	PI3K-ABD.	NA			epidermal growth factor receptor signaling pathway|fibroblast growth factor receptor signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell costimulation|T cell receptor signaling pathway		1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity			NS(16)|autonomic_ganglia(4)|biliary_tract(22)|bone(1)|breast(2150)|central_nervous_system(110)|cervix(33)|endometrium(473)|eye(1)|haematopoietic_and_lymphoid_tissue(35)|kidney(14)|large_intestine(1202)|liver(42)|lung(202)|meninges(1)|oesophagus(28)|ovary(235)|pancreas(17)|penis(8)|pituitary(12)|prostate(10)|skin(155)|small_intestine(1)|soft_tissue(18)|stomach(121)|thyroid(80)|upper_aerodigestive_tract(70)|urinary_tract(208)	5269	all_cancers(143;1.19e-17)|Ovarian(172;0.00769)|Breast(254;0.155)		OV - Ovarian serous cystadenocarcinoma(80;9.59e-28)|GBM - Glioblastoma multiforme(14;0.003)|BRCA - Breast invasive adenocarcinoma(182;0.0282)			AAAGTAATTGAACCAGTAGGC	0.348		57	Mis		"""colorectal, gastric, gliobastoma, breast"""		NA			HNSCC(19;0.045)|TSP Lung(28;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(199;1504 1750 3362 26421 31210 32040)		Dom	yes		3	3q26.3	5290	"""phosphoinositide-3-kinase, catalytic, alpha polypeptide"""	NA	"""E, O"""	0													93	88	90			NA	NA	3		NA											NA				178916921		1817	4070	5887	SO:0001583	missense			ENSG00000121879	HGNC:8975		Approved	uc003fjk.3	NA	Q14CW1|Q99762	ENST00000263967.3	37	CCDS43171.1	.	.	.	.	.	.	.	.	.	.	A	21.1	4.094708	0.76870	.	.	ENSG00000121879	ENST00000263967;ENST00000468036	T;T	0.74632	-0.86;-0.86	5.52	5.52	0.82312	Phosphatidylinositol 3-kinase, p85-binding (2);	0.000000	0.85682	D	0.000000	D	0.84813	0.5555	M	0.73217	2.22	0.80722	D	1	D	0.76494	0.999	D	0.72982	0.979	D	0.85252	0.1045	9	.	.	.	-15.5947	15.6301	0.76899	1.0:0.0:0.0:0.0	.	103	P42336	PK3CA_HUMAN	G	103	ENSP00000263967:E103G;ENSP00000417479:E103G	.	E	+	2	0	PIK3CA	180399615	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	7.155000	0.77445	2.089000	0.63090	0.454000	0.30748	GAA	PIK3CA-001	KNOWN	basic|exp_conf|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000348409.2	217.110653	KEEP		+	217.319229	0.458015	60	71	---	---	---	---	1	0.980636	4	6	0	204	75	84	0	204	2	1	1	39	206	2	293	75	84	0	204	7	TP
SLC30A9	10463	broad.mit.edu	37	4	42022431	42022431	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr4:42022431A>T	ENST00000264451.6	+	4	514		c.e4-1			NM_006345.3	NP_006336.3	Q6PML9	ZNT9_HUMAN	solute carrier family 30 (zinc transporter), member 9	NA		NA			nucleotide-excision repair|zinc ion transport	cytoskeleton|integral to membrane|nucleus	cation transmembrane transporter activity|nucleotide binding|sequence-specific DNA binding transcription factor activity			central_nervous_system(2)|endometrium(4)|kidney(2)|large_intestine(8)|lung(6)|ovary(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	25						TTTTTTGTTTAGTTAAAGCAG	0.348		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													126	115	119			NA	NA	4		NA											NA				42022431		2203	4299	6502	SO:0001630	splice_region_variant			ENSG00000014824	HGNC:1329		Approved	uc003gwl.3	NA	Q4W5B6|Q7Z5I7|Q8TBB2|Q9Y6R2	ENST00000264451.6	37	CCDS3465.1	.	.	.	.	.	.	.	.	.	.	A	25.0	4.592832	0.86953	.	.	ENSG00000014824	ENST00000264451	.	.	.	5.95	5.95	0.96441	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.4116	0.83717	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SLC30A9	41717188	1.000000	0.71417	1.000000	0.80357	0.960000	0.62799	8.788000	0.91834	2.276000	0.75962	0.528000	0.53228	.	SLC30A9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000216842.2	-12.808821	KEEP	Intron	+	8.404485	0.050505	5	94	---	---	---	---	1	0.9468408	119	1	0	215	5	109	0	215	2	0	0	0	0	0	0	5	109	0	215	2	TP
SMARCA5	8467	broad.mit.edu	37	4	144468559	144468559	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr4:144468559A>G	ENST00000283131.3	+	21	3137	c.2675A>G	c.(2674-2676)aAc>aGc	p.N892S		NM_003601.3	NP_003592.3	O60264	SMCA5_HUMAN	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5	892	SANT 1.	NA			CenH3-containing nucleosome assembly at centromere|nucleosome positioning|regulation of transcription from RNA polymerase II promoter|transcription initiation, DNA-dependent	condensed chromosome|nucleolus|nucleoplasm|NURF complex|RSF complex	ATP binding|ATPase activity|DNA binding|helicase activity|nucleosome binding|protein binding		EWSR1/SMARCA5(2)	endometrium(2)|kidney(2)|large_intestine(9)|lung(4)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	21	all_hematologic(180;0.158)					GAAAGGTGCAACGAGCTCCAG	0.353		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0								A	SER/ASN	0,4406		0,0,2203	86	86	86		2675	5.4	1	4		86	3,8597	3.0+/-9.4	0,3,4297	yes	missense	SMARCA5	NM_003601.3	46	0,3,6500	GG,GA,AA	NA	0.0349,0.0,0.0231	benign	892/1053	144468559	3,13003	2203	4300	6503	SO:0001583	missense			ENSG00000153147	HGNC:11101		Approved	uc003ijg.3	NA		ENST00000283131.3	37	CCDS3761.1	.	.	.	.	.	.	.	.	.	.	A	12.90	2.075646	0.36662	0.0	3.49E-4	ENSG00000153147	ENST00000283131;ENST00000536484;ENST00000535006	D	0.90504	-2.68	5.41	5.41	0.78517	Homeodomain-like (1);SANT, eukarya (1);	0.000000	0.85682	D	0.000000	D	0.84374	0.5458	L	0.28014	0.82	0.58432	D	0.999999	B	0.02656	0.0	B	0.04013	0.001	T	0.79427	-0.1808	10	0.21540	T	0.41	-2.3095	15.4609	0.75356	1.0:0.0:0.0:0.0	.	892	O60264	SMCA5_HUMAN	S	892;835;835	ENSP00000283131:N892S	ENSP00000283131:N892S	N	+	2	0	SMARCA5	144688009	1.000000	0.71417	1.000000	0.80357	0.959000	0.62525	9.231000	0.95317	2.051000	0.60960	0.528000	0.53228	AAC	SMARCA5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000365077.3	-30.106675	KEEP		+	6.900926	0.020833	3	141	---	---	---	---	1	0.9938463	2	368	0	157	5	176	0	157	2	0	0	0	0	0	0	5	176	0	157	2	TP
RAI14	26064	broad.mit.edu	37	5	34814686	34814686	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:34814686A>T	ENST00000265109.3	+	12	1139		c.e12-1		RAI14_ENST00000428746.2_Splice_Site|RAI14_ENST00000515799.1_Splice_Site|RAI14_ENST00000506376.1_Splice_Site|RAI14_ENST00000397449.1_Splice_Site|RAI14_ENST00000512629.1_Splice_Site|RAI14_ENST00000503673.1_Splice_Site	NM_001145522.1|NM_015577.2	NP_001138994.1|NP_056392.2	Q9P0K7	RAI14_HUMAN	retinoic acid induced 14	NA		NA				cell cortex|cytoskeleton	protein binding			breast(2)|central_nervous_system(1)|endometrium(2)|kidney(4)|large_intestine(19)|lung(22)|ovary(1)|prostate(1)|skin(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	56	all_lung(31;0.000191)					TTTCTTTTTTAGTTGAGTGAT	0.368		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													103	93	96			NA	NA	5		NA											NA				34814686		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000039560	HGNC:14873	NM_015577	Approved	uc011coj.2	NA	Q6V1W9|Q7Z5I4|Q7Z733|Q9P2L2|Q9Y3T5	ENST00000265109.3	37	CCDS34142.1	.	.	.	.	.	.	.	.	.	.	A	21.4	4.147539	0.77888	.	.	ENSG00000039560	ENST00000265109;ENST00000512629;ENST00000428746;ENST00000503673;ENST00000515799;ENST00000506376;ENST00000397449	.	.	.	5.86	5.86	0.93980	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.5602	0.84551	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	RAI14	34850443	1.000000	0.71417	0.989000	0.46669	0.830000	0.47004	6.041000	0.70988	2.367000	0.80283	0.528000	0.53228	.	RAI14-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000366786.1	4.240335	KEEP	Intron	+	16.27107	0.103896	8	69	---	---	---	---	1	0.7657371	26	2	0	147	9	85	0	147	2	0	0	0	0	0	0	9	85	0	147	2	TP
YTHDC2	64848	broad.mit.edu	37	5	112884236	112884236	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:112884236A>T	ENST00000161863.4	+	11	1708		c.e11-1		YTHDC2_ENST00000515883.1_Splice_Site	NM_022828.3	NP_073739.3	Q9H6S0	YTDC2_HUMAN	YTH domain containing 2	NA		NA					ATP binding|ATP-dependent helicase activity|nucleic acid binding			NS(2)|central_nervous_system(2)|cervix(1)|endometrium(2)|kidney(6)|large_intestine(13)|lung(10)|pancreas(1)|prostate(3)|skin(2)|upper_aerodigestive_tract(1)	43		all_cancers(142;7.69e-05)|all_epithelial(76;6.42e-07)|Colorectal(10;0.00278)|Prostate(80;0.00955)|Ovarian(225;0.0444)|Lung NSC(810;0.143)|all_lung(232;0.163)|Breast(839;0.244)		OV - Ovarian serous cystadenocarcinoma(64;7.2e-08)|Epithelial(69;8.83e-08)|all cancers(49;6.9e-06)|COAD - Colon adenocarcinoma(37;0.0458)|Colorectal(14;0.0594)		TCCTTTTTTTAGTTGATTACA	0.348		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													61	64	63			NA	NA	5		NA											NA				112884236		2202	4300	6502	SO:0001630	splice_region_variant			ENSG00000047188	HGNC:24721	NM_022828	Approved	uc003kqn.3	NA	B2RP66	ENST00000161863.4	37	CCDS4113.1	.	.	.	.	.	.	.	.	.	.	A	23.7	4.447481	0.84101	.	.	ENSG00000047188	ENST00000161863;ENST00000515883;ENST00000511372	.	.	.	5.43	5.43	0.79202	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.7527	0.77997	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	YTHDC2	112912135	1.000000	0.71417	0.957000	0.39632	0.944000	0.59088	8.996000	0.93539	2.180000	0.69256	0.455000	0.32223	.	YTHDC2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250776.2	3.90676	KEEP	Intron	+	12.738509	0.105263	6	51	---	---	---	---	1	0.4356943	13	0	0	130	7	61	0	130	2	0	0	0	0	0	0	7	61	0	130	2	TP
DMXL1	1657	broad.mit.edu	37	5	118532064	118532064	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:118532064A>T	ENST00000311085.8	+	31	7537		c.e31-1		DMXL1_ENST00000539542.1_Splice_Site	NM_005509.4	NP_005500.4	Q9Y485	DMXL1_HUMAN	Dmx-like 1	NA		NA								breast(3)|central_nervous_system(1)|endometrium(14)|kidney(4)|large_intestine(20)|liver(6)|lung(28)|ovary(2)|prostate(5)|skin(2)|upper_aerodigestive_tract(1)	86		all_cancers(142;0.0314)|all_epithelial(76;0.00559)|Prostate(80;0.11)|Breast(839;0.231)		OV - Ovarian serous cystadenocarcinoma(64;0.000563)|Epithelial(69;0.00179)|all cancers(49;0.0243)		CTTTATTTTTAGTTGGTCCTT	0.388		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													204	189	194			NA	NA	5		NA											NA				118532064		2202	4300	6502	SO:0001630	splice_region_variant			ENSG00000172869	HGNC:2937	NM_005509	Approved	uc003ksd.2	NA		ENST00000311085.8	37	CCDS4125.1	.	.	.	.	.	.	.	.	.	.	A	21.2	4.106784	0.77096	.	.	ENSG00000172869	ENST00000311085;ENST00000539542	.	.	.	5.44	5.44	0.79542	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.1512	0.72700	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	DMXL1	118559963	1.000000	0.71417	0.999000	0.59377	0.810000	0.45777	8.345000	0.90057	2.068000	0.61886	0.383000	0.25322	.	DMXL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250862.1	-58.697945	KEEP	Intron	+	24.652037	0.043011	16	356	---	---	---	---	1	0.2667214	26	0	0	265	18	471	0	265	2	0	0	0	0	0	0	18	471	0	265	2	TP
DMXL1	1657	broad.mit.edu	37	5	118573014	118573014	+	Intron	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:118573014A>T	ENST00000311085.8	+	39	8483				DMXL1_ENST00000539542.1_Intron|DMXL1_ENST00000505312.1_Intron	NM_005509.4	NP_005500.4	Q9Y485	DMXL1_HUMAN	Dmx-like 1	NA		NA								breast(3)|central_nervous_system(1)|endometrium(14)|kidney(4)|large_intestine(20)|liver(6)|lung(28)|ovary(2)|prostate(5)|skin(2)|upper_aerodigestive_tract(1)	86		all_cancers(142;0.0314)|all_epithelial(76;0.00559)|Prostate(80;0.11)|Breast(839;0.231)		OV - Ovarian serous cystadenocarcinoma(64;0.000563)|Epithelial(69;0.00179)|all cancers(49;0.0243)		ttCTTTCTCTAAGTTTGGAAT	0.313		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													NA	NA	NA			NA	NA			NA											NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000172869	HGNC:2937	NM_005509	Approved	uc003ksd.2	NA		ENST00000311085.8	37	CCDS4125.1																																																																																			DMXL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250862.1	-3.279275	KEEP		+	9.172783	0.074627	5	62	---	---	---	---	1	0.4079032	18	0	0	177	5	69	0	177	2	0	0	0	0	0	0	5	69	0	177	2	TP
ALDH7A1	501	broad.mit.edu	37	5	125891709	125891709	+	Splice_Site	SNP	T	T	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:125891709T>A	ENST00000409134.3	-	12	1228		c.e12-2		ALDH7A1_ENST00000553117.1_Intron|RNU6-963P_ENST00000363477.1_RNA|ALDH7A1_ENST00000447989.2_Intron	NM_001182.4|NM_001201377.1	NP_001173.2|NP_001188306.1	P49419	AL7A1_HUMAN	aldehyde dehydrogenase 7 family, member A1	NA		NA			cellular aldehyde metabolic process|lysine catabolic process|sensory perception of sound	cytosol|mitochondrial matrix|nucleus	aldehyde dehydrogenase (NAD) activity|betaine-aldehyde dehydrogenase activity|L-aminoadipate-semialdehyde dehydrogenase activity			endometrium(1)|kidney(4)|large_intestine(4)|lung(5)|ovary(1)|upper_aerodigestive_tract(1)	16		all_cancers(142;0.24)|Prostate(80;0.081)	KIRC - Kidney renal clear cell carcinoma(527;0.0584)|Kidney(363;0.0934)	Epithelial(69;0.0417)|OV - Ovarian serous cystadenocarcinoma(64;0.068)|all cancers(49;0.109)	NADH(DB00157)|Pyridoxine(DB00165)	ATGTATAAACTAAACGAAAAA	0.348		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													72	70	71			NA	NA	5		NA											NA				125891709		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000164904	HGNC:877	NM_001182	Approved	uc003ktx.3	NA	B2R669|B4DIC7|O14619|Q6IPU8|Q9BUL4	ENST00000409134.3	37	CCDS4137.2	.	.	.	.	.	.	.	.	.	.	T	11.04	1.523184	0.27211	.	.	ENSG00000164904	ENST00000409134;ENST00000437170	.	.	.	5.26	5.26	0.73747	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.1229	0.72460	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	ALDH7A1	125919608	1.000000	0.71417	0.985000	0.45067	0.102000	0.19082	5.396000	0.66297	2.127000	0.65507	0.533000	0.62120	.	ALDH7A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250921.2	-14.61073	KEEP	Intron	-	8.273663	0.047619	5	100	---	---	---	---	1	0.999423	7	2	0	107	5	123	0	107	2	0	0	0	0	0	0	5	123	0	107	2	TP
REEP2	51308	broad.mit.edu	37	5	137781275	137781275	+	Silent	SNP	G	G	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:137781275G>A	ENST00000378339.2	+	7	876	c.684G>A	c.(682-684)gcG>gcA	p.A228A	REEP2_ENST00000506158.1_Silent_p.A188A|REEP2_ENST00000254901.5_Silent_p.A226A	NM_001271803.1	NP_001258732.1	Q9BRK0	REEP2_HUMAN	receptor accessory protein 2	226		NA				integral to membrane				endometrium(1)|kidney(1)|large_intestine(4)|lung(3)|ovary(1)|prostate(1)|urinary_tract(1)	12			KIRC - Kidney renal clear cell carcinoma(527;0.004)|Kidney(363;0.00592)			TCAAAAAAGCGCCCAAAGCTG	0.592		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0								G		1,4405	2.1+/-5.4	0,1,2202	50	55	53		678	-2.5	0.8	5		53	0,8600		0,0,4300	no	coding-synonymous	REEP2	NM_016606.2		0,1,6502	AA,AG,GG	NA	0.0,0.0227,0.0077		226/253	137781275	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000132563	HGNC:17975	NM_016606	Approved	uc003lda.4	NA	Q53EM8|Q9NYF2	ENST00000378339.2	37																																																																																				REEP2-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000251283.1	69.240577	KEEP		+	69.450309	0.431373	22	29	---	---	---	---	1	1	133	193	0	72	28	35	0	72	2	0	0	0	0	0	0	28	35	0	72	2	TP
MAML1	9794	broad.mit.edu	37	5	179192466	179192466	+	Missense_Mutation	SNP	C	C	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr5:179192466C>A	ENST00000292599.3	+	2	718	c.455C>A	c.(454-456)tCc>tAc	p.S152Y	MAML1_ENST00000503050.1_3'UTR	NM_014757.4	NP_055572.1	Q92585	MAML1_HUMAN	mastermind-like 1 (Drosophila)	152		NA			Notch signaling pathway|positive regulation of transcription from RNA polymerase II promoter|transcription, DNA-dependent	nuclear speck	peptide antigen binding|protein kinase binding|transcription coactivator activity			central_nervous_system(1)|cervix(2)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(4)|lung(16)|ovary(2)|prostate(3)|skin(1)|upper_aerodigestive_tract(1)	36	all_cancers(89;0.000197)|all_epithelial(37;6.7e-05)|Renal(175;0.000159)|Lung NSC(126;0.00121)|all_lung(126;0.00218)	all_cancers(40;0.0308)|Medulloblastoma(196;0.00498)|all_neural(177;0.0138)	Kidney(164;2.23e-05)|KIRC - Kidney renal clear cell carcinoma(164;0.000178)			GCCATCTCTTCCAATGGACTG	0.602		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													45	50	48			NA	NA	5		NA											NA				179192466		2203	4300	6503	SO:0001583	missense				HGNC:13632	NM_014757	Approved	uc003mkm.3	NA	Q9NZ12	ENST00000292599.3	37	CCDS34315.1	.	.	.	.	.	.	.	.	.	.	C	15.47	2.842446	0.51057	.	.	ENSG00000161021	ENST00000292599;ENST00000376951	T	0.48836	0.8	5.11	5.11	0.69529	.	0.378995	0.25319	N	0.031533	T	0.64283	0.2584	M	0.64997	1.995	0.43777	D	0.996308	D;P	0.62365	0.991;0.95	P;P	0.59643	0.861;0.629	T	0.67237	-0.5721	10	0.62326	D	0.03	-7.934	18.5375	0.91015	0.0:1.0:0.0:0.0	.	189;152	Q59GH4;Q92585	.;MAML1_HUMAN	Y	152;189	ENSP00000292599:S152Y	ENSP00000292599:S152Y	S	+	2	0	MAML1	179125072	1.000000	0.71417	0.957000	0.39632	0.393000	0.30537	5.321000	0.65846	2.367000	0.80283	0.462000	0.41574	TCC	MAML1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000372316.2	212.749313	KEEP		+	213.779038	0.415663	69	97	---	---	---	---	1	0.9999971	15	18	0	102	84	123	0	102	2	0	0	0	0	0	0	84	123	0	102	2	TP
JARID2	3720	broad.mit.edu	37	6	15520428	15520428	+	Silent	SNP	C	C	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr6:15520428C>T	ENST00000341776.2	+	18	3931	c.3687C>T	c.(3685-3687)ccC>ccT	p.P1229P	JARID2_ENST00000397311.3_Silent_p.P1057P	NM_004973.3	NP_004964.2	Q92833	JARD2_HUMAN	jumonji, AT rich interactive domain 2	1229		NA			central nervous system development|chromatin modification|negative regulation of histone methylation|positive regulation of histone H3-K9 methylation|stem cell differentiation|transcription, DNA-dependent		chromatin binding			breast(1)|central_nervous_system(1)|cervix(1)|endometrium(10)|kidney(2)|large_intestine(15)|lung(19)|ovary(3)|pancreas(1)|prostate(5)|stomach(1)	59	Breast(50;0.0142)|Ovarian(93;0.103)	all_hematologic(90;0.00612)				TGGACGTGCCCCCCTCCCGTC	0.488		NA					NA						C	1	5e-04	NA	NA	2184	NA	1	,	,	NA	2e-04	0.0013	NA	NA	5e-04	1	EXOME	NA	NA	0.001	SNP								NA		NA		0								C		0,4406		0,0,2203	81	78	79		3687	-1	1	6		79	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	JARID2	NM_004973.2		0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077		1229/1247	15520428	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000008083	HGNC:6196	NM_004973	Approved	uc003nbj.4	NA	A8K9Z6|B7Z5S5|Q5U5L5|Q86X63	ENST00000341776.2	37	CCDS4533.1																																																																																			JARID2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000039926.1	99.735362	KEEP		+	100.830902	0.375	30	50	---	---	---	---	1	1	41	67	0	175	44	76	0	175	2	0	0	0	0	0	0	44	76	0	175	2	TP
SLC35F1	222553	broad.mit.edu	37	6	118635189	118635189	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr6:118635189A>T	ENST00000360388.4	+	8	1203		c.e8-1			NM_001029858.3	NP_001025029.2	Q5T1Q4	S35F1_HUMAN	solute carrier family 35, member F1	NA		NA			transport	integral to membrane				breast(3)|kidney(1)|large_intestine(7)|lung(21)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)	36				GBM - Glioblastoma multiforme(226;0.217)		GTGTTTTTTTAGTTTTCAGGA	0.473		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													NA	NA	NA			NA	NA			NA											NA				NA		NA	NA	NA	SO:0001630	splice_region_variant			ENSG00000196376	HGNC:21483	XM_167044	Approved	uc003pxx.4	NA	E1P564|Q1RMG1|Q4G0U9|Q4G167|Q6N007	ENST00000360388.4	37	CCDS34524.1	.	.	.	.	.	.	.	.	.	.	A	20.2	3.953854	0.73902	.	.	ENSG00000196376	ENST00000360388	.	.	.	5.71	5.71	0.89125	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.9822	0.80121	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SLC35F1	118741882	1.000000	0.71417	0.995000	0.50966	0.908000	0.53690	7.987000	0.88182	2.186000	0.69663	0.533000	0.62120	.	SLC35F1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041991.2	-20.198837	KEEP	Intron	+	13.047052	0.051282	8	148	---	---	---	---	1	0.9480504	100	2	0	122	8	153	0	122	2	0	0	0	0	0	0	8	153	0	122	2	TP
PEX7	5191	broad.mit.edu	37	6	137193334	137193334	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr6:137193334A>T	ENST00000541292.1	+	9	941		c.e9-1		PEX7_ENST00000318471.4_Splice_Site			O00628	PEX7_HUMAN	peroxisomal biogenesis factor 7	NA		NA			ether lipid biosynthetic process|protein import into peroxisome matrix	peroxisome	peroxisome matrix targeting signal-2 binding			lung(7)|prostate(1)	8	Colorectal(23;0.24)			GBM - Glioblastoma multiforme(68;0.000257)|OV - Ovarian serous cystadenocarcinoma(155;0.00492)		TTTTTTTTGTAGTTTTCACCA	0.303		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													97	103	101			NA	NA	6		NA											NA				137193334		2202	4297	6499	SO:0001630	splice_region_variant			ENSG00000112357	HGNC:8860	NM_000288	Approved	uc003qhd.3	NA		ENST00000541292.1	37		.	.	.	.	.	.	.	.	.	.	A	8.362	0.833252	0.16820	.	.	ENSG00000112357	ENST00000318471	.	.	.	5.37	4.18	0.49190	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.9359	0.47245	0.8592:0.0:0.0:0.1408	.	.	.	.	.	-1	.	.	.	+	.	.	PEX7	137235027	1.000000	0.71417	0.762000	0.31397	0.005000	0.04900	7.050000	0.76620	0.949000	0.37715	-0.480000	0.04831	.	PEX7-201	KNOWN	basic	protein_coding	NA	protein_coding		-26.455797	KEEP	Intron	+	10.595752	0.042424	7	158	---	---	---	---	1	0.1656903	56	22	5	240	9	210	5	240	6	0	0	0	0	0	0	9	210	5	240	2	TP
HECA	51696	broad.mit.edu	37	6	139487771	139487771	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr6:139487771G>A	ENST00000367658.2	+	2	907	c.622G>A	c.(622-624)Gag>Aag	p.E208K	RP1-225E12.2_ENST00000587577.1_RNA|RP1-225E12.2_ENST00000586266.1_RNA|RP1-225E12.2_ENST00000591102.1_RNA|RP1-225E12.3_ENST00000585874.1_RNA|RP1-225E12.2_ENST00000588638.1_RNA|RP1-225E12.2_ENST00000586229.1_RNA|RP1-225E12.2_ENST00000588529.1_RNA|RP1-225E12.2_ENST00000590679.1_RNA|RP1-225E12.2_ENST00000589192.1_RNA|RP1-225E12.2_ENST00000415194.2_RNA	NM_016217.2	NP_057301.1	Q9UBI9	HDC_HUMAN	headcase homolog (Drosophila)	208		NA			respiratory tube development					endometrium(4)|kidney(1)|large_intestine(3)|lung(4)|ovary(1)|prostate(1)|skin(1)	15				GBM - Glioblastoma multiforme(68;0.000252)|OV - Ovarian serous cystadenocarcinoma(155;0.000387)		GTCTGGCTCCGAGAAGAACAC	0.592		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													39	45	42			NA	NA	6		NA											NA				139487771		2203	4300	6503	SO:0001583	missense			ENSG00000112406	HGNC:21041	NM_016217	Approved	uc003qin.3	NA		ENST00000367658.2	37	CCDS5194.1	.	.	.	.	.	.	.	.	.	.	G	21.1	4.096141	0.76870	.	.	ENSG00000112406	ENST00000367658	.	.	.	5.13	5.13	0.70059	.	0.155014	0.51477	D	0.000083	T	0.56834	0.2012	L	0.27053	0.805	0.80722	D	1	D	0.89917	1.0	D	0.79108	0.992	T	0.51926	-0.8643	9	0.27082	T	0.32	.	18.7842	0.91947	0.0:0.0:1.0:0.0	.	208	Q9UBI9	HDC_HUMAN	K	208	.	ENSP00000356630:E208K	E	+	1	0	HECA	139529464	1.000000	0.71417	0.960000	0.40013	0.874000	0.50279	9.142000	0.94618	2.676000	0.91093	0.655000	0.94253	GAG	HECA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000042456.1	151.694719	KEEP		+	153.10092	0.389313	51	80	---	---	---	---	1	0.9878738	5	9	0	97	57	89	0	97	2	0	0	0	0	0	0	57	89	0	97	2	TP
OSBPL3	26031	broad.mit.edu	37	7	24854824	24854824	+	Splice_Site	SNP	T	T	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:24854824T>A	ENST00000313367.2	-	19	2479		c.e19-2		OSBPL3_ENST00000409069.1_Splice_Site|OSBPL3_ENST00000487020.1_5'Flank|OSBPL3_ENST00000352860.1_Splice_Site|OSBPL3_ENST00000431825.2_Splice_Site|OSBPL3_ENST00000396431.1_Splice_Site|OSBPL3_ENST00000353930.1_Splice_Site|OSBPL3_ENST00000396429.1_Splice_Site	NM_015550.2	NP_056365.1	Q9H4L5	OSBL3_HUMAN	oxysterol binding protein-like 3	NA		NA			lipid transport		lipid binding|protein binding			breast(2)|central_nervous_system(1)|endometrium(5)|kidney(1)|large_intestine(10)|lung(19)|prostate(1)|skin(3)|urinary_tract(1)	43						TCCCCAAAACTAAAAAGAAGG	0.378		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													72	71	71			NA	NA	7		NA											NA				24854824		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000070882	HGNC:16370		Approved	uc003sxf.3	NA	A4D167|A4D168|A4D169|A4D170|A4D171|A4D172|B8ZZ79|B8ZZP0|O14591|O43357|O43358|Q8N702|Q8N703|Q8N704|Q8NFH0|Q8NFH1|Q8NI12|Q8NI13|Q9BZF4|Q9UED6	ENST00000313367.2	37	CCDS5390.1	.	.	.	.	.	.	.	.	.	.	T	28.2	4.899311	0.91962	.	.	ENSG00000070882	ENST00000313367;ENST00000352860;ENST00000353930;ENST00000431825;ENST00000396431;ENST00000396429;ENST00000409069	.	.	.	4.67	4.67	0.58626	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.387	0.66953	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	OSBPL3	24821349	1.000000	0.71417	0.111000	0.21465	0.961000	0.63080	8.037000	0.88933	1.876000	0.54355	0.379000	0.24179	.	OSBPL3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000214085.2	-25.140955	KEEP	Intron	-	7.641391	0.035714	5	135	---	---	---	---	1	0.6476044	63	0	0	162	5	150	0	162	2	0	0	0	0	0	0	5	150	0	162	2	TP
NOD1	10392	broad.mit.edu	37	7	30492358	30492358	+	Silent	SNP	G	G	A	rs150842987		GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:30492358G>A	ENST00000222823.4	-	6	1200	c.675C>T	c.(673-675)gaC>gaT	p.D225D	NOD1_ENST00000423334.2_Intron	NM_006092.2	NP_006083.1	Q9Y239	NOD1_HUMAN	nucleotide-binding oligomerization domain containing 1	225	NACHT.	NA			activation of MAPK activity|detection of bacterium|induction of apoptosis|inflammatory response|innate immune response|interleukin-8 biosynthetic process|JNK cascade|MyD88-dependent toll-like receptor signaling pathway|MyD88-independent toll-like receptor signaling pathway|positive regulation of dendritic cell antigen processing and presentation|positive regulation of I-kappaB kinase/NF-kappaB cascade|positive regulation of NF-kappaB transcription factor activity|protein oligomerization|stress-activated MAPK cascade|Toll signaling pathway|toll-like receptor 1 signaling pathway|toll-like receptor 2 signaling pathway|toll-like receptor 3 signaling pathway|toll-like receptor 4 signaling pathway	basolateral plasma membrane|cytosol	ATP binding|CARD domain binding|caspase activator activity|peptidoglycan binding|protein homodimerization activity			breast(1)|central_nervous_system(2)|endometrium(6)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(5)|lung(17)|ovary(2)|prostate(1)|skin(2)	39						TGACCCCTGCGTCTAGCCGGC	0.577		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													69	73	71			NA	NA	7		NA											NA				30492358		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000106100	HGNC:16390		Approved	uc003tav.3	NA	Q549U4|Q8IWF5	ENST00000222823.4	37	CCDS5427.1																																																																																			NOD1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250443.2	147.637773	KEEP		-	149.974053	0.360294	49	87	---	---	---	---	1	0.9412276	3	4	0	114	51	102	0	114	2	0	0	0	0	0	0	51	102	0	114	2	TP
VPS41	27072	broad.mit.edu	37	7	38835094	38835094	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:38835094G>C	ENST00000310301.4	-	9	742	c.688C>G	c.(688-690)Ctg>Gtg	p.L230V	VPS41_ENST00000395969.2_Missense_Mutation_p.L205V|VPS41_ENST00000466017.1_5'UTR	NM_014396.3	NP_055211.2	P49754	VPS41_HUMAN	vacuolar protein sorting 41 homolog (S. cerevisiae)	230		NA			Golgi vesicle transport|intracellular protein transport|vesicle-mediated transport	cytosol|Golgi-associated vesicle|HOPS complex|membrane fraction	zinc ion binding			NS(1)|breast(1)|central_nervous_system(2)|endometrium(5)|kidney(4)|large_intestine(5)|lung(17)|ovary(1)|prostate(2)|skin(2)|upper_aerodigestive_tract(4)	44						CCAATAATCAGTGTCACATTG	0.468		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													108	97	101			NA	NA	7		NA											NA				38835094		2203	4300	6503	SO:0001583	missense			ENSG00000006715	HGNC:12713		Approved	uc003tgy.3	NA	Q86TP8|Q99851|Q99852	ENST00000310301.4	37	CCDS5457.1	.	.	.	.	.	.	.	.	.	.	G	32	5.176513	0.94846	.	.	ENSG00000006715	ENST00000310301;ENST00000395969;ENST00000413141	T;T;T	0.60548	0.18;0.18;0.27	5.82	5.82	0.92795	WD40 repeat-like-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.79551	0.4465	M	0.82823	2.61	0.80722	D	1	D;D	0.76494	0.999;0.999	D;D	0.78314	0.991;0.991	T	0.80450	-0.1377	10	0.59425	D	0.04	-11.5681	20.0852	0.97797	0.0:0.0:1.0:0.0	.	205;230	E9PF36;P49754	.;VPS41_HUMAN	V	230;205;156	ENSP00000309457:L230V;ENSP00000379297:L205V;ENSP00000412974:L156V	ENSP00000309457:L230V	L	-	1	2	VPS41	38801619	1.000000	0.71417	0.987000	0.45799	0.950000	0.60333	9.808000	0.99193	2.756000	0.94617	0.561000	0.74099	CTG	VPS41-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000226986.3	78.594348	KEEP		-	99.530737	0.161458	31	161	---	---	---	---	1	0.9999258	20	94	1	164	49	245	1	164	5	0	0	0	0	0	0	49	245	1	164	2	TP
EGFR	1956	broad.mit.edu	37	7	55221822	55221822	+	Missense_Mutation	SNP	C	C	A	rs149840192		GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:55221822C>A	ENST00000275493.2	+	7	1043	c.866C>A	c.(865-867)gCc>gAc	p.A289D	EGFR_ENST00000455089.1_Missense_Mutation_p.A244D|EGFR_ENST00000442591.1_Missense_Mutation_p.A289D|EGFR_ENST00000420316.2_Missense_Mutation_p.A289D|EGFR_ENST00000344576.2_Missense_Mutation_p.A289D|EGFR_ENST00000342916.3_Missense_Mutation_p.A289D|EGFR_ENST00000454757.2_Missense_Mutation_p.A236D	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	289		NA			activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.A289V(20)|p.A289D(3)		NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	AGCTTTGGTGCCACCTGCGTG	0.592		8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC	NA		Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	23	Substitution - Missense(23)	central_nervous_system(23)											178	142	154			NA	NA	7		NA											NA				55221822		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	C	35	5.459485	0.96240	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000395504;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T;T;T;T	0.62941	-0.01;-0.01;-0.01;-0.01;-0.01;-0.01;-0.01	5.94	5.94	0.96194	Growth factor, receptor (1);Furin-like cysteine-rich domain (1);	0.000000	0.85682	D	0.000000	T	0.73992	0.3658	L	0.41710	1.295	0.80722	D	1	P;D;P;D;P	0.69078	0.933;0.997;0.954;0.991;0.685	B;D;P;P;B	0.79784	0.424;0.993;0.652;0.649;0.241	T	0.74890	-0.3510	10	0.87932	D	0	.	18.9232	0.92534	0.0:1.0:0.0:0.0	.	244;289;289;289;289	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	D	244;289;159;289;289;289;289;236;83	ENSP00000415559:A244D;ENSP00000342376:A289D;ENSP00000345973:A289D;ENSP00000413843:A289D;ENSP00000275493:A289D;ENSP00000410031:A289D;ENSP00000395243:A236D	ENSP00000275493:A289D	A	+	2	0	EGFR	55189316	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	7.794000	0.85869	2.816000	0.96949	0.563000	0.77884	GCC	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	3232.991619	KEEP		+	3366.208853	0.945917	892	51	---	---	---	---	1	1	752	48	0	94	1073	58	0	94	2	1	1	166	16	5	199	1073	58	0	94	11	TP
COPS6	10980	broad.mit.edu	37	7	99687418	99687418	+	Intron	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:99687418A>T	ENST00000303904.3	+	3	371				COPS6_ENST00000418625.1_Intron	NM_006833.4	NP_006824.2	Q7L5N1	CSN6_HUMAN	COP9 signalosome subunit 6	NA		NA			cullin deneddylation|interspecies interaction between organisms	cytoplasm|signalosome	protein binding			breast(1)|endometrium(3)|large_intestine(4)|lung(2)|prostate(1)|stomach(1)	12	Lung NSC(181;0.0181)|all_lung(186;0.0284)|Esophageal squamous(72;0.0439)		STAD - Stomach adenocarcinoma(171;0.129)			TAAAAAAAAAATGTACAGGGT	0.433		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													27	26	26			NA	NA	7		NA											NA				99687418		2203	4300	6503	SO:0001627	intron_variant			ENSG00000168090	HGNC:21749	NM_006833	Approved	uc003usu.3	NA	A4D2A3|O15387	ENST00000303904.3	37	CCDS5682.1																																																																																			COPS6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336412.3	13.526786	KEEP		+	17.319227	0.166667	6	30	---	---	---	---	1	1	836	3	0	35	6	32	0	35	2	0	0	0	0	0	0	6	32	0	35	2	TP
LRWD1	222229	broad.mit.edu	37	7	102106371	102106371	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:102106371C>T	ENST00000292616.5	+	2	340	c.188C>T	c.(187-189)cCg>cTg	p.P63L	ALKBH4_ENST00000292566.3_5'Flank|MIR5090_ENST00000582533.1_RNA	NM_152892.1	NP_690852.1	Q9UFC0	LRWD1_HUMAN	leucine-rich repeats and WD repeat domain containing 1	63		NA			chromatin modification|DNA-dependent DNA replication initiation|establishment of protein localization to chromatin|G1 phase of mitotic cell cycle	centromeric heterochromatin|nuclear origin of replication recognition complex|telomeric heterochromatin	chromatin binding|methyl-CpG binding|methylated histone residue binding	p.P63L(1)		central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(2)|large_intestine(3)|lung(7)|ovary(1)|skin(1)|stomach(2)	20						GAGACGCTGCCGGACAACCTG	0.622		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		1	Substitution - Missense(1)	large_intestine(1)						C	LEU/PRO	0,4406		0,0,2203	48	49	49		188	5	0.6	7		49	1,8599	1.2+/-3.3	0,1,4299	no	missense	LRWD1	NM_152892.1	98	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	probably-damaging	63/648	102106371	1,13005	2203	4300	6503	SO:0001583	missense			ENSG00000161036	HGNC:21769	NM_152892	Approved	uc003uzn.3	NA	A8K4K2|B2R9G2|Q8N0T9|Q8WV43|Q96GJ2	ENST00000292616.5	37	CCDS34715.1	.	.	.	.	.	.	.	.	.	.	C	33	5.218050	0.95104	0.0	1.16E-4	ENSG00000161036	ENST00000292616	T	0.28895	1.59	5.04	5.04	0.67666	.	0.000000	0.85682	D	0.000000	T	0.63343	0.2503	M	0.88310	2.945	0.80722	D	1	D	0.89917	1.0	D	0.91635	0.999	T	0.71932	-0.4443	10	0.87932	D	0	-11.7684	17.3718	0.87380	0.0:1.0:0.0:0.0	.	63	Q9UFC0	LRWD1_HUMAN	L	63	ENSP00000292616:P63L	ENSP00000292616:P63L	P	+	2	0	LRWD1	101893376	1.000000	0.71417	0.551000	0.28230	0.937000	0.57800	6.846000	0.75399	2.349000	0.79799	0.561000	0.74099	CCG	LRWD1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000349493.1	11.126406	KEEP		+	14.705029	0.171429	6	29	---	---	---	---	1	0.9999959	48	131	0	83	8	40	0	83	2	0	0	0	0	0	0	8	40	0	83	2	TP
PTN	5764	broad.mit.edu	37	7	136912652	136912652	+	3'UTR	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:136912652A>T	ENST00000348225.2	-	0	1049				PTN_ENST00000393083.2_3'UTR	NM_002825.5	NP_002816.1	P21246	PTN_HUMAN	pleiotrophin	NA		NA			nervous system development|positive regulation of cell division|positive regulation of cell proliferation|transmembrane receptor protein tyrosine phosphatase signaling pathway	endoplasmic reticulum|extracellular space	growth factor activity|heparin binding|protein phosphatase inhibitor activity			NS(1)|endometrium(1)|kidney(1)|large_intestine(5)|lung(10)|pancreas(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	23						GTTTTTGCTTATTGTGTACTT	0.289		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													NA	NA	NA			NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000105894	HGNC:9630	NM_002825	Approved	uc003vtq.2	NA	Q5U0B0|Q6ICQ5|Q9UCC6	ENST00000348225.2	37	CCDS5844.1																																																																																			PTN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000341339.1	-5.186597	KEEP		-	9.418601	0.066667	5	70	---	---	---	---	1	1	4	2385	0	69	5	70	0	69	2	0	0	0	0	0	0	5	70	0	69	2	TP
PTN	5764	broad.mit.edu	37	7	136912659	136912659	+	3'UTR	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr7:136912659A>T	ENST00000348225.2	-	0	1042				PTN_ENST00000393083.2_3'UTR	NM_002825.5	NP_002816.1	P21246	PTN_HUMAN	pleiotrophin	NA		NA			nervous system development|positive regulation of cell division|positive regulation of cell proliferation|transmembrane receptor protein tyrosine phosphatase signaling pathway	endoplasmic reticulum|extracellular space	growth factor activity|heparin binding|protein phosphatase inhibitor activity			NS(1)|endometrium(1)|kidney(1)|large_intestine(5)|lung(10)|pancreas(1)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	23						CTTATTGTGTACTTAGCTATA	0.303		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													NA	NA	NA			NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000105894	HGNC:9630	NM_002825	Approved	uc003vtq.2	NA	Q5U0B0|Q6ICQ5|Q9UCC6	ENST00000348225.2	37	CCDS5844.1																																																																																			PTN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000341339.1	0.92874	KEEP		-	16.305107	0.088889	8	82	---	---	---	---	1	1	10	2088	0	77	8	82	0	77	2	0	0	0	0	0	0	8	82	0	77	2	TP
CYP2C8	1558	broad.mit.edu	37	10	96827051	96827051	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr10:96827051C>T	ENST00000371270.3	-	3	489	c.395G>A	c.(394-396)cGg>cAg	p.R132Q	CYP2C8_ENST00000535898.1_Missense_Mutation_p.R30Q|CYP2C8_ENST00000539050.1_Missense_Mutation_p.R46Q	NM_000770.3|NM_001198853.1|NM_001198855.1	NP_000761.3|NP_001185782.1|NP_001185784.1	P10632	CP2C8_HUMAN	cytochrome P450, family 2, subfamily C, polypeptide 8	132		NA			exogenous drug catabolic process|organic acid metabolic process|oxidative demethylation|xenobiotic metabolic process	endoplasmic reticulum membrane|microsome	aromatase activity|caffeine oxidase activity|electron carrier activity|heme binding|oxygen binding			breast(1)|endometrium(3)|kidney(3)|large_intestine(5)|lung(6)|skin(3)	21		Colorectal(252;0.0397)		all cancers(201;6.21e-05)	Aminophenazone(DB01424)|Amiodarone(DB01118)|Amodiaquine(DB00613)|Benzphetamine(DB00865)|Carbamazepine(DB00564)|Cerivastatin(DB00439)|Diclofenac(DB00586)|Fluvastatin(DB01095)|Fosphenytoin(DB01320)|Gemfibrozil(DB01241)|Ketoconazole(DB01026)|Lapatinib(DB01259)|Lovastatin(DB00227)|Midazolam(DB00683)|Montelukast(DB00471)|Nicardipine(DB00622)|Paclitaxel(DB01229)|Phenytoin(DB00252)|Pioglitazone(DB01132)|Repaglinide(DB00912)|Rifampin(DB01045)|Rosiglitazone(DB00412)|Simvastatin(DB00641)|Sitagliptin(DB01261)|Tolbutamide(DB01124)|Torasemide(DB00214)|Tretinoin(DB00755)|Trimethoprim(DB00440)|Warfarin(DB00682)|Zafirlukast(DB00549)|Zopiclone(DB01198)	CCCAAAATTCCGCAAGGTTGT	0.483		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													175	161	166			NA	NA	10		NA											NA				96827051		2203	4300	6503	SO:0001583	missense			ENSG00000138115	HGNC:2622	NM_000770	Approved	uc001kkb.3	NA	A8K9N8|B0AZN2|Q5VX93|Q8WWB1|Q9UCZ9	ENST00000371270.3	37	CCDS7438.1	.	.	.	.	.	.	.	.	.	.	C	24.1	4.491800	0.84962	.	.	ENSG00000138115	ENST00000371270;ENST00000535868;ENST00000535898;ENST00000539050	T;T;T	0.12879	2.64;2.64;2.64	4.64	4.64	0.57946	.	0.000000	0.64402	U	0.000001	T	0.38692	0.1050	M	0.91818	3.245	0.37299	D	0.908616	D;D;D;D	0.69078	0.997;0.997;0.989;0.997	P;P;P;P	0.54210	0.629;0.745;0.674;0.745	T	0.60419	-0.7267	10	0.87932	D	0	.	16.221	0.82258	0.0:1.0:0.0:0.0	.	46;30;100;132	F5H7Q9;B7Z1F6;B7Z8S1;P10632	.;.;.;CP2C8_HUMAN	Q	132;99;30;46	ENSP00000360317:R132Q;ENSP00000445062:R30Q;ENSP00000442343:R46Q	ENSP00000360317:R132Q	R	-	2	0	CYP2C8	96817041	0.149000	0.22717	0.426000	0.26672	0.564000	0.35744	2.975000	0.49281	2.424000	0.82194	0.561000	0.74099	CGG	CYP2C8-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000049499.2	1442.442659	KEEP		-	1497.02694	0.851852	391	68	---	---	---	---	1	0.9864955	4	0	0	257	457	82	0	257	2	0	0	0	0	0	0	457	82	0	257	2	TP
NEURL	0	broad.mit.edu	37	10	105331407	105331407	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr10:105331407G>T	ENST00000369780.4	+	3	886	c.477G>T	c.(475-477)gaG>gaT	p.E159D	NEURL_ENST00000369777.2_Missense_Mutation_p.E142D	NM_004210.4	NP_004201.3	O76050	NEU1A_HUMAN		159	NHR 1.	NA			nervous system development	perinuclear region of cytoplasm	zinc ion binding			endometrium(3)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(1)|lung(4)|ovary(2)|pancreas(1)|prostate(1)|upper_aerodigestive_tract(1)	17				Epithelial(162;2.12e-09)|all cancers(201;6.99e-08)|BRCA - Breast invasive adenocarcinoma(275;0.125)		CGCTGCCTGAGGAGTTTGCCA	0.612		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													120	81	94			NA	NA	10		NA											NA				105331407		2203	4300	6503	SO:0001583	missense								NA	Q5TDR2|Q5TDR3|Q8TAN0|Q9H463	ENST00000369780.4	37	CCDS7551.1	.	.	.	.	.	.	.	.	.	.	G	18.95	3.730777	0.69074	.	.	ENSG00000107954	ENST00000369780;ENST00000437579;ENST00000369777;ENST00000455386	T;T	0.30981	1.51;1.51	5.79	4.89	0.63831	NEUZ (2);	0.000000	0.85682	D	0.000000	T	0.42899	0.1223	L	0.42632	1.34	0.80722	D	1	D	0.71674	0.998	D	0.74674	0.984	T	0.35151	-0.9800	10	0.59425	D	0.04	-17.5358	7.534	0.27700	0.2503:0.0:0.7497:0.0	.	159	O76050	NEU1A_HUMAN	D	159;142;142;84	ENSP00000358795:E159D;ENSP00000358792:E142D	ENSP00000358792:E142D	E	+	3	2	NEURL	105321397	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	1.524000	0.35942	1.451000	0.47736	0.561000	0.74099	GAG	NEURL-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000050170.1	10.858794	KEEP		+	13.158602	0.192308	5	21	---	---	---	---	1	0.8009163	5	7	0	49	8	26	0	49	2	0	0	0	0	0	0	8	26	0	49	2	TP
SDHAF2	54949	broad.mit.edu	37	11	61205474	61205474	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr11:61205474A>T	ENST00000301761.2	+	3	334		c.e3-1		RP11-286N22.8_ENST00000544880.1_Splice_Site|SDHAF2_ENST00000537782.1_Splice_Site|SDHAF2_ENST00000534878.1_Splice_Site|RP11-286N22.8_ENST00000543044.1_Splice_Site|SDHAF2_ENST00000543265.1_Intron|SDHAF2_ENST00000542074.1_Intron	NM_017841.2	NP_060311.1	Q9NX18	SDHF2_HUMAN	succinate dehydrogenase complex assembly factor 2	NA		NA			mitochondrial electron transport, succinate to ubiquinone|protein-FAD linkage	mitochondrion	protein binding			large_intestine(3)|lung(4)|ovary(2)	9						TCTTGTTTTTAGTCTTTTTGC	0.403		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													96	93	94			NA	NA	11		NA											NA				61205474		2202	4299	6501	SO:0001630	splice_region_variant			ENSG00000167985	HGNC:26034	NM_017841	Approved	uc001nrt.3	NA		ENST00000301761.2	37	CCDS8007.1	.	.	.	.	.	.	.	.	.	.	A	17.89	3.500876	0.64298	.	.	ENSG00000256591;ENSG00000167985	ENST00000541135;ENST00000301761	.	.	.	5.91	5.91	0.95273	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.3309	0.74208	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	SDHAF2;RP11-286N22.8	60962050	1.000000	0.71417	0.977000	0.42913	0.540000	0.34992	8.106000	0.89555	2.254000	0.74563	0.533000	0.62120	.	SDHAF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000398438.1	-40.061078	KEEP	Intron	+	10.983704	0.03271	7	207	---	---	---	---	1	0.9974879	322	36	0	205	7	229	0	205	2	0	0	0	0	0	0	7	229	0	205	2	TP
UVRAG	7405	broad.mit.edu	37	11	75590966	75590966	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr11:75590966G>A	ENST00000356136.3	+	4	555	c.314G>A	c.(313-315)cGt>cAt	p.R105H	UVRAG_ENST00000528420.1_Missense_Mutation_p.R4H	NM_003369.3	NP_003360.2	Q9P2Y5	UVRAG_HUMAN	UV radiation resistance associated	105	C2.	NA			DNA repair|positive regulation of autophagy	early endosome|late endosome|lysosome	protein binding			central_nervous_system(1)|cervix(3)|endometrium(3)|kidney(1)|large_intestine(2)|lung(15)|skin(5)|urinary_tract(2)	32						ATGCCAGACCGTCTTGATACA	0.423		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0								G	HIS/ARG	1,4399	2.1+/-5.4	0,1,2199	272	258	263		314	0.5	1	11		263	0,8586		0,0,4293	yes	missense	UVRAG	NM_003369.3	29	0,1,6492	AA,AG,GG	NA	0.0,0.0227,0.0077	benign	105/700	75590966	1,12985	2200	4293	6493	SO:0001583	missense			ENSG00000198382	HGNC:12640	NM_003369	Approved	uc001oxc.3	NA	O00392	ENST00000356136.3	37	CCDS8241.1	.	.	.	.	.	.	.	.	.	.	G	13.75	2.330074	0.41297	2.27E-4	0.0	ENSG00000198382	ENST00000356136;ENST00000528420;ENST00000528264	T	0.42900	0.96	5.65	0.455	0.16649	C2 calcium-dependent membrane targeting (1);	0.287349	0.38778	N	0.001573	T	0.32315	0.0825	L	0.47716	1.5	0.80722	D	1	B	0.18310	0.027	B	0.17098	0.017	T	0.10613	-1.0622	10	0.36615	T	0.2	-3.107	9.9666	0.41727	0.4571:0.0:0.5429:0.0	.	105	Q9P2Y5	UVRAG_HUMAN	H	105;4;4	ENSP00000348455:R105H	ENSP00000348455:R105H	R	+	2	0	UVRAG	75268614	0.439000	0.25610	0.992000	0.48379	0.996000	0.88848	0.772000	0.26647	0.167000	0.19631	-0.302000	0.09304	CGT	UVRAG-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000383430.1	1073.945839	KEEP		+	1075.209252	0.454545	320	384	---	---	---	---	1	0.9985235	9	7	1	547	397	512	1	547	2	0	0	0	0	0	0	397	512	1	547	2	TP
NOP2	4839	broad.mit.edu	37	12	6675301	6675301	+	Missense_Mutation	SNP	T	T	G			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr12:6675301T>G	ENST00000541778.1	-	5	916	c.428A>C	c.(427-429)gAc>gCc	p.D143A	NOP2_ENST00000542015.1_Intron|NOP2_ENST00000537442.1_Missense_Mutation_p.D147A|NOP2_ENST00000322166.5_Missense_Mutation_p.D147A|NOP2_ENST00000382421.3_Missense_Mutation_p.D147A|NOP2_ENST00000545200.1_Missense_Mutation_p.D143A|NOP2_ENST00000399466.2_Missense_Mutation_p.D143A			P46087	NOP2_HUMAN	NOP2 nucleolar protein	147		NA			positive regulation of cell proliferation|rRNA processing	nucleolus	protein binding|RNA binding|S-adenosylmethionine-dependent methyltransferase activity			breast(1)|kidney(2)|large_intestine(5)|lung(8)|ovary(2)|upper_aerodigestive_tract(1)	19						AGAGTTGGAGTCAGCTCCATA	0.488		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													74	77	76			NA	NA	12		NA											NA				6675301		2138	4229	6367	SO:0001583	missense			ENSG00000111641	HGNC:7867	NM_006170	Approved	uc021qtz.2	NA	A1A4Z3|B3KPD6|Q0P5S5|Q58F30	ENST00000541778.1	37	CCDS44811.1	.	.	.	.	.	.	.	.	.	.	T	10.06	1.247015	0.22796	.	.	ENSG00000111641	ENST00000537442;ENST00000382421;ENST00000545200;ENST00000399466;ENST00000322166;ENST00000541778;ENST00000542944;ENST00000542867;ENST00000536124;ENST00000545492	T;T;T;T;T;T;T;T;T;T	0.51817	2.28;2.5;2.38;2.3;2.28;2.3;0.69;0.93;0.94;0.91	4.86	1.08	0.20341	.	2.407120	0.01889	N	0.038384	T	0.31136	0.0787	N	0.12746	0.255	0.09310	N	1	B;B	0.06786	0.001;0.001	B;B	0.09377	0.003;0.004	T	0.19679	-1.0298	10	0.44086	T	0.13	-7.1763	5.4483	0.16548	0.0:0.1104:0.4652:0.4244	.	147;143	Q3KQS4;P46087-2	.;.	A	147;147;143;143;147;143;23;143;147;147	ENSP00000444437:D147A;ENSP00000371858:D147A;ENSP00000439422:D143A;ENSP00000382392:D143A;ENSP00000313272:D147A;ENSP00000443150:D143A;ENSP00000440754:D23A;ENSP00000443035:D143A;ENSP00000442895:D147A;ENSP00000441923:D147A	ENSP00000313272:D147A	D	-	2	0	NOP2	6545562	0.000000	0.05858	0.036000	0.18154	0.948000	0.59901	-0.227000	0.09126	0.191000	0.20236	0.482000	0.46254	GAC	NOP2-005	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402615.1	71.330956	KEEP		-	73.898129	0.30137	22	51	---	---	---	---	1	1	36	45	0	54	36	65	0	54	2	0	0	0	0	0	0	36	65	0	54	2	TP
C1S	716	broad.mit.edu	37	12	7172402	7172402	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr12:7172402A>T	ENST00000406697.1	+	9	1145		c.e9-1		C1S_ENST00000402681.3_Splice_Site|C1S_ENST00000328916.3_Splice_Site|C1S_ENST00000360817.5_Splice_Site			P09871	C1S_HUMAN	complement component 1, s subcomponent	NA		NA			complement activation, classical pathway|innate immune response|proteolysis	extracellular region	calcium ion binding|serine-type endopeptidase activity			breast(1)|endometrium(5)|kidney(2)|large_intestine(8)|liver(4)|lung(8)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	33					Abciximab(DB00054)|Adalimumab(DB00051)|Basiliximab(DB00074)|Cetuximab(DB00002)|Etanercept(DB00005)|Gemtuzumab ozogamicin(DB00056)|Ibritumomab(DB00078)|Immune globulin(DB00028)|Muromonab(DB00075)|Rituximab(DB00073)|Trastuzumab(DB00072)	TTTCTCTGTTAGTTAATTGCA	0.418		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(156;750 1943 12971 24779 31015)							NA		NA		0													66	65	65			NA	NA	12		NA											NA				7172402		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000182326	HGNC:1247	NM_001734	Approved	uc001qsl.3	NA	D3DUT4|Q9UCU7|Q9UCU8|Q9UCU9|Q9UCV0|Q9UCV1|Q9UCV2|Q9UCV3|Q9UCV4|Q9UCV5|Q9UM14	ENST00000406697.1	37	CCDS31735.1	.	.	.	.	.	.	.	.	.	.	A	11.79	1.745149	0.30955	.	.	ENSG00000182326	ENST00000406697;ENST00000328916;ENST00000360817;ENST00000382222;ENST00000402681;ENST00000542978	.	.	.	6.17	6.17	0.99709	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	16.0034	0.80327	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	C1S	7042663	1.000000	0.71417	0.987000	0.45799	0.181000	0.23173	7.053000	0.76641	2.371000	0.80710	0.533000	0.62120	.	C1S-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000317481.1	-13.01172	KEEP	Intron	+	14.447032	0.059259	8	127	---	---	---	---	1	0.9983618	160	5	0	134	10	140	0	134	2	0	0	0	0	0	0	10	140	0	134	2	TP
A2ML1	144568	broad.mit.edu	37	12	8998036	8998036	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr12:8998036A>T	ENST00000299698.7	+	13	1656		c.e13-1		A2ML1_ENST00000539547.1_Splice_Site|A2ML1_ENST00000540049.1_3'UTR	NM_144670.4	NP_653271.2	B3KVV6	B3KVV6_HUMAN	alpha-2-macroglobulin-like 1	NA		NA				extracellular space	endopeptidase inhibitor activity			NS(2)|breast(5)|endometrium(5)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(18)|liver(2)|lung(36)|ovary(2)|skin(4)|stomach(1)|urinary_tract(1)	80						TTTCTTCTTTAGTTAATAGGG	0.428		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													74	73	73			NA	NA	12		NA											NA				8998036		1867	4096	5963	SO:0001630	splice_region_variant			ENSG00000166535	HGNC:23336	NM_144670	Approved	uc001quz.5	NA		ENST00000299698.7	37	CCDS8596.2	.	.	.	.	.	.	.	.	.	.	A	13.60	2.286896	0.40494	.	.	ENSG00000166535	ENST00000299698;ENST00000539161;ENST00000541459;ENST00000536789;ENST00000539547;ENST00000545692	.	.	.	4.0	2.86	0.33363	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	6.9493	0.24536	0.804:0.0:0.196:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	A2ML1	8889303	1.000000	0.71417	0.856000	0.33681	0.964000	0.63967	4.210000	0.58500	0.884000	0.36064	0.459000	0.35465	.	A2ML1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000250304.3	-31.599084	KEEP	Intron	+	7.713734	0.030675	5	158	---	---	---	---	1	0.01738587	6	0	0	115	6	199	0	115	2	0	0	0	0	0	0	6	199	0	115	2	TP
CCDC91	55297	broad.mit.edu	37	12	28458580	28458580	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr12:28458580A>T	ENST00000545336.1	+	7	528		c.e7-1		CCDC91_ENST00000540401.1_Splice_Site|CCDC91_ENST00000381256.1_Splice_Site|CCDC91_ENST00000306172.5_Splice_Site|CCDC91_ENST00000539107.1_Splice_Site|CCDC91_ENST00000381259.1_Splice_Site			Q7Z6B0	CCD91_HUMAN	coiled-coil domain containing 91	NA		NA			protein transport	Golgi apparatus|membrane				NS(1)|breast(3)|central_nervous_system(1)|endometrium(1)|kidney(2)|large_intestine(5)|lung(8)|skin(1)	22	Acute lymphoblastic leukemia(23;0.00718)|all_hematologic(23;0.0113)|Lung SC(9;0.184)					GTTTTTCTTTAGTATCTGGAG	0.393		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													191	185	187			NA	NA	12		NA											NA				28458580		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:24855	NM_018318	Approved	uc001riq.3	NA	B3KSA3|C9JR07|Q68D43|Q6IA78|Q8NEN7|Q9NUW9	ENST00000545336.1	37	CCDS8716.1	.	.	.	.	.	.	.	.	.	.	A	10.50	1.368066	0.24771	.	.	ENSG00000123106	ENST00000538586;ENST00000539107;ENST00000536442;ENST00000545336;ENST00000543534;ENST00000545737;ENST00000381259;ENST00000381256;ENST00000306172	.	.	.	4.86	4.86	0.63082	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.0599	0.47942	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	CCDC91	28349847	0.998000	0.40836	0.923000	0.36655	0.233000	0.25261	4.431000	0.59915	2.172000	0.68678	0.477000	0.44152	.	CCDC91-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000402447.1	-184.009294	KEEP	Intron	+	13.906913	0.014865	11	729	---	---	---	---	1	0.1331545	48	1	1	474	11	925	1	474	2	0	0	0	0	0	0	11	925	1	474	2	TP
UFM1	51569	broad.mit.edu	37	13	38932228	38932228	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr13:38932228A>T	ENST00000379641.1	+	3	171		c.e3-1		UFM1_ENST00000379649.1_Splice_Site|UFM1_ENST00000239878.4_Splice_Site			P61960	UFM1_HUMAN	ubiquitin-fold modifier 1	NA		NA			protein ufmylation	cytoplasm|nucleus	protein binding			lung(2)|ovary(1)	3		Lung NSC(96;3.18e-06)|Prostate(109;0.00314)|Breast(139;0.0199)|Lung SC(185;0.0743)		all cancers(112;1.05e-08)|Epithelial(112;1.44e-06)|OV - Ovarian serous cystadenocarcinoma(117;0.000855)|BRCA - Breast invasive adenocarcinoma(63;0.00342)|GBM - Glioblastoma multiforme(144;0.0132)		CCTTCTATTTAGTTTAAAGTT	0.274		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													12	12	12			NA	NA	13		NA											NA				38932228		2068	4150	6218	SO:0001630	splice_region_variant			ENSG00000120686	HGNC:20597	NM_016617	Approved	uc001uwu.3	NA	Q14346|Q5VXS0|Q6IAG6|Q9CPX2|Q9NZF2	ENST00000379641.1	37		.	.	.	.	.	.	.	.	.	.	A	16.36	3.101820	0.56183	.	.	ENSG00000120686	ENST00000379649;ENST00000239878;ENST00000437952;ENST00000379641	.	.	.	5.07	5.07	0.68467	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.7678	0.57401	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	UFM1	37830228	1.000000	0.71417	0.994000	0.49952	0.770000	0.43624	6.622000	0.74233	1.899000	0.54978	0.482000	0.46254	.	UFM1-201	KNOWN	basic	protein_coding	NA	protein_coding		8.023303	KEEP	Intron	+	8.054537	0.428571	3	4	---	---	---	---	1	0.9999371	116	0	0	45	3	5	0	45	2	0	0	0	0	0	0	3	5	0	45	2	TP
DCAF11	0	broad.mit.edu	37	14	24587957	24587957	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr14:24587957A>T	ENST00000446197.3	+	8	1451		c.e8-1		RP11-468E2.6_ENST00000558325.1_5'Flank|DCAF11_ENST00000396941.4_Splice_Site|DCAF11_ENST00000396936.1_Splice_Site|DCAF11_ENST00000559115.1_Splice_Site	NM_025230.4	NP_079506.3	Q8TEB1	DCA11_HUMAN	DDB1 and CUL4 associated factor 11	NA		NA				CUL4 RING ubiquitin ligase complex	protein binding				NA						TGCTTCTCTTAGTTCATATCT	0.463		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													173	146	155			NA	NA	14		NA											NA				24587957		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000100897	HGNC:20258		Approved	uc001wlv.3	NA	B3KQ83|D3DS56|Q5D039|Q86U00|Q86U39|Q8NDN2|Q9H2J0|Q9H3A3|Q9H5C9	ENST00000446197.3	37	CCDS9610.1	.	.	.	.	.	.	.	.	.	.	a	16.59	3.165130	0.57476	.	.	ENSG00000100897	ENST00000326009;ENST00000446197;ENST00000396936;ENST00000396941	.	.	.	5.05	5.05	0.67936	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	12.7873	0.57514	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	DCAF11	23657797	1.000000	0.71417	1.000000	0.80357	0.933000	0.57130	7.189000	0.77747	2.125000	0.65367	0.533000	0.62120	.	DCAF11-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000071907.4	-46.678541	KEEP	Intron	+	11.258234	0.029412	7	231	---	---	---	---	1	0.9535286	199	0	0	216	8	293	0	216	2	0	0	0	0	0	0	8	293	0	216	2	TP
TECPR2	9895	broad.mit.edu	37	14	102891314	102891314	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr14:102891314A>T	ENST00000359520.7	+	6	864		c.e6-1		TECPR2_ENST00000561228.1_Intron|TECPR2_ENST00000558678.1_Splice_Site	NM_014844.3	NP_055659.2	O15040	TCPR2_HUMAN	tectonin beta-propeller repeat containing 2	NA		NA					protein binding	p.?(1)		breast(1)|central_nervous_system(1)|endometrium(6)|kidney(3)|large_intestine(7)|lung(21)|ovary(2)|prostate(3)|skin(4)|stomach(1)|urinary_tract(1)	50						TTCTAATTTTAGTACTGGGAA	0.383		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		1	Unknown(1)	prostate(1)											65	75	71			NA	NA	14		NA											NA				102891314		2196	4298	6494	SO:0001630	splice_region_variant				HGNC:19957	NM_014844	Approved	uc001ylw.2	NA	A6NFY9|A7E2X3|Q9UEG6	ENST00000359520.7	37	CCDS32162.1	.	.	.	.	.	.	.	.	.	.	a	21.3	4.123248	0.77436	.	.	ENSG00000196663	ENST00000359520;ENST00000380088	.	.	.	5.18	5.18	0.71444	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.0521	0.71881	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	TECPR2	101961067	1.000000	0.71417	0.859000	0.33776	0.993000	0.82548	8.068000	0.89490	1.959000	0.56917	0.451000	0.29950	.	TECPR2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000415056.2	-22.948498	KEEP	Intron	+	7.223389	0.031746	4	122	---	---	---	---	1	0.3733969	36	0	0	150	5	156	0	150	2	0	0	0	0	0	0	5	156	0	150	2	TP
CTDSPL2	51496	broad.mit.edu	37	15	44751187	44751187	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr15:44751187A>T	ENST00000260327.4	+	2	539		c.e2-1		CTDSPL2_ENST00000396780.1_Splice_Site|CTDSPL2_ENST00000558373.1_5'Flank|CTDSPL2_ENST00000558966.1_Splice_Site	NM_016396.2	NP_057480.2	Q05D32	CTSL2_HUMAN	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2	NA		NA					phosphoprotein phosphatase activity			breast(1)|endometrium(1)|kidney(2)|large_intestine(3)|lung(4)|upper_aerodigestive_tract(2)	13		all_cancers(109;4.36e-14)|all_epithelial(112;9.8e-12)|Lung NSC(122;1.66e-07)|all_lung(180;1.47e-06)|Melanoma(134;0.0122)		all cancers(107;1.02e-20)|GBM - Glioblastoma multiforme(94;1.49e-06)|COAD - Colon adenocarcinoma(120;0.0857)|Colorectal(105;0.0905)		tttCTCTTTTAGTTTTACATG	0.343		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													35	38	37			NA	NA	15		NA											NA				44751187		2195	4296	6491	SO:0001630	splice_region_variant			ENSG00000137770	HGNC:26936	NM_016396	Approved	uc001ztr.3	NA	Q3ZTU1|Q6AI06|Q8IYI9|Q9NVT2|Q9NZX8|Q9P030	ENST00000260327.4	37	CCDS10110.1																																																																																			CTDSPL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253851.1	4.679405	KEEP	Intron	+	13.855624	0.112903	7	55	---	---	---	---	1	0.9332435	31	8	0	105	8	62	0	105	2	0	0	0	0	0	0	8	62	0	105	2	TP
NETO2	81831	broad.mit.edu	37	16	47165938	47165938	+	Splice_Site	SNP	T	T	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr16:47165938T>A	ENST00000562435.1	-	2	419		c.e2-2		NETO2_ENST00000303155.5_Splice_Site	NM_018092.4	NP_060562.3	Q8NC67	NETO2_HUMAN	neuropilin (NRP) and tolloid (TLL)-like 2	NA		NA				integral to membrane	receptor activity			breast(1)|cervix(1)|endometrium(1)|large_intestine(8)|lung(11)|prostate(1)|skin(2)|upper_aerodigestive_tract(4)	29		all_cancers(37;0.00114)|all_lung(18;0.00432)|Lung NSC(13;0.0384)|Breast(268;0.174)				TTAACAACACTAGAGAAATAA	0.313		NA					NA			HNSCC(25;0.065)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													173	166	168			NA	NA	16		NA											NA				47165938		2202	4300	6502	SO:0001630	splice_region_variant			ENSG00000171208	HGNC:14644	NM_018092	Approved	uc002eer.2	NA	Q7Z381|Q8ND51|Q96SP4|Q9NVY8	ENST00000562435.1	37	CCDS10727.1	.	.	.	.	.	.	.	.	.	.	T	22.3	4.270482	0.80469	.	.	ENSG00000171208	ENST00000303155	.	.	.	5.33	5.33	0.75918	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.2987	0.73931	0.0:0.0:0.0:1.0	.	.	.	.	.	-1	.	.	.	-	.	.	NETO2	45723439	1.000000	0.71417	0.986000	0.45419	0.967000	0.64934	6.001000	0.70685	1.999000	0.58509	0.455000	0.32223	.	NETO2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256766.2	-66.31608	KEEP	Intron	-	13.386632	0.027778	9	315	---	---	---	---	1	0.6365966	2	0	0	456	12	375	0	456	2	0	0	0	0	0	0	12	375	0	456	2	TP
TP53	7157	broad.mit.edu	37	17	7577538	7577538	+	Missense_Mutation	SNP	C	C	T	rs11540652		GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr17:7577538C>T	ENST00000420246.2	-	7	875	c.743G>A	c.(742-744)cGg>cAg	p.R248Q	TP53_ENST00000445888.2_Missense_Mutation_p.R248Q|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000413465.2_Missense_Mutation_p.R248Q|TP53_ENST00000455263.2_Missense_Mutation_p.R248Q|TP53_ENST00000269305.4_Missense_Mutation_p.R248Q|TP53_ENST00000359597.4_Missense_Mutation_p.R248Q	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	248	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Interacts with the 53BP2 SH3 domain.	NA	NR -> IP (in a sporadic cancer; somatic mutation).|NR -> KW (in sporadic cancers; somatic mutation).|R -> C (in a sporadic cancer; somatic mutation).|R -> G (in sporadic cancers; somatic mutation).|R -> L (in sporadic cancers; somatic mutation).|R -> P (in sporadic cancers; somatic mutation).|R -> Q (in LFS; germline mutation and in sporadic cancers; somatic mutation; dbSNP:rs11540652).|R -> W (in LFS; germline mutation and in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.R248Q(580)|p.R248L(75)|p.R248P(19)|p.R155Q(18)|p.0?(8)|p.?(5)|p.R155L(3)|p.R155P(2)|p.N247_R248delNR(2)|p.R248fs*16(2)|p.M246_P250delMNRRP(2)|p.R248_P250delRRP(1)|p.unknown(1)|p.N247_R249delNRR(1)|p.N247_P250delNRRP(1)|p.R249fs*96(1)|p.R248fs*>39(1)|p.R248C(1)|p.G245fs*14(1)|p.N247_R248>IP(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GATGGGCCTCCGGTTCATGCC	0.572	R248Q(BL41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(CA46_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(CI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(DB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(HCC1143_BREAST)|R248Q(HCC70_BREAST)|R248Q(HEC1A_ENDOMETRIUM)|R248Q(HS683_CENTRAL_NERVOUS_SYSTEM)|R248Q(HSC4_UPPER_AERODIGESTIVE_TRACT)|R248Q(KASUMI1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KOPN8_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KYO1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(KYSE150_OESOPHAGUS)|R248Q(MOLM6_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NAMALWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NB4_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(NCIH211_LUNG)|R248Q(NCIN87_STOMACH)|R248Q(NIHOVCAR3_OVARY)|R248Q(NUDHL1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(P12ICHIKAWA_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(PANC0203_PANCREAS)|R248Q(PC14_LUNG)|R248Q(PF382_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(RT112_URINARY_TRACT)|R248Q(SEM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(SF295_CENTRAL_NERVOUS_SYSTEM)|R248Q(SKUT1_SOFT_TISSUE)|R248Q(SUPT1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)|R248Q(SW1463_LARGE_INTESTINE)|R248Q(WSUDLCL2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE)	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	725	Substitution - Missense(698)|Whole gene deletion(8)|Deletion - In frame(7)|Unknown(6)|Insertion - Frameshift(3)|Deletion - Frameshift(2)|Complex - compound substitution(1)	large_intestine(138)|breast(83)|haematopoietic_and_lymphoid_tissue(74)|lung(71)|upper_aerodigestive_tract(63)|central_nervous_system(46)|oesophagus(37)|urinary_tract(37)|ovary(36)|stomach(35)|endometrium(23)|skin(18)|prostate(11)|bone(10)|biliary_tract(9)|liver(9)|pancreas(7)|vulva(3)|kidney(3)|cervix(3)|peritoneum(2)|thyroid(2)|soft_tissue(1)|pituitary(1)|adrenal_gland(1)|small_intestine(1)|thymus(1)	GRCh37	CM920675	TP53	M	rs11540652	C	GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG,GLN/ARG	0,4406		0,0,2203	152	112	126	http://www.ncbi.nlm.nih.gov/sites/varvu?gene	743,743,743,743,347,347,347	3.7	1	17	dbSNP_120	126	1,8599	1.2+/-3.3	0,1,4299	no	missense,missense,missense,missense,missense,missense,missense	TP53	NM_000546.4,NM_001126112.1,NM_001126113.1,NM_001126114.1,NM_001126115.1,NM_001126116.1,NM_001126117.1	43,43,43,43,43,43,43	0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077	probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging,probably-damaging	248/394,248/394,248/347,248/342,116/262,116/210,116/215	7577538	1,13005	2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	C	27.3	4.822907	0.90873	0.0	1.16E-4	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944	D;D;D;D;D;D;D;D	0.99864	-7.28;-7.28;-7.28;-7.28;-7.28;-7.28;-7.28;-7.28	4.62	3.65	0.41850	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99840	0.9927	M	0.88640	2.97	0.58432	A	0.999994	D;D;D;D;D;D	0.89917	1.0;0.994;1.0;1.0;1.0;1.0	D;P;D;D;D;D	0.91635	0.996;0.882;0.999;0.995;0.996;0.995	D	0.96819	0.9602	9	0.72032	D	0.01	-9.5643	10.6687	0.45745	0.0:0.9059:0.0:0.0941	rs11540652;rs11540652	248;248;155;248;248;248	P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;P53_HUMAN;.;.	Q	248;248;248;248;248;248;237;155;116;155	ENSP00000410739:R248Q;ENSP00000352610:R248Q;ENSP00000269305:R248Q;ENSP00000398846:R248Q;ENSP00000391127:R248Q;ENSP00000391478:R248Q;ENSP00000425104:R116Q;ENSP00000423862:R155Q	ENSP00000269305:R248Q	R	-	2	0	TP53	7518263	1.000000	0.71417	1.000000	0.80357	0.887000	0.51463	5.884000	0.69729	1.305000	0.44909	0.462000	0.41574	CGG	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	576.301589	KEEP		-	577.953151	0.43073	171	226	---	---	---	---	1	1	180	225	0	80	207	307	0	80	2	1	1	290	323	0	608	207	307	0	80	2	TP
TP53	7157	broad.mit.edu	37	17	7578550	7578550	+	Missense_Mutation	SNP	G	G	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr17:7578550G>T	ENST00000420246.2	-	5	512	c.380C>A	c.(379-381)tCc>tAc	p.S127Y	TP53_ENST00000445888.2_Missense_Mutation_p.S127Y|TP53_ENST00000574684.1_5'Flank|TP53_ENST00000413465.2_Missense_Mutation_p.S127Y|TP53_ENST00000455263.2_Missense_Mutation_p.S127Y|TP53_ENST00000269305.4_Missense_Mutation_p.S127Y|TP53_ENST00000359597.4_Missense_Mutation_p.S127Y	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	127	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	S -> C (in a sporadic cancer; somatic mutation).|S -> F (in sporadic cancers; somatic mutation).|S -> P (in sporadic cancers; somatic mutation).|S -> T (in sporadic cancers; somatic mutation).|S -> Y (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.S127F(23)|p.0?(8)|p.S127Y(8)|p.S127C(7)|p.Y126_K132delYSPALNK(6)|p.A129fs*20(3)|p.Y126_N131delYSPALN(3)|p.S34C(2)|p.P128fs*42(2)|p.V73fs*9(1)|p.S127fs*36(1)|p.P128fs*18(1)|p.Y126fs*11(1)|p.S127_Q136del10(1)|p.P13fs*18(1)|p.?(1)|p.S34F(1)|p.A36fs*20(1)|p.S127fs*42(1)|p.Y126fs*18(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		GAGGGCAGGGGAGTACTGTAG	0.552		111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	73	Substitution - Missense(41)|Deletion - In frame(10)|Deletion - Frameshift(9)|Whole gene deletion(8)|Insertion - Frameshift(4)|Unknown(1)	lung(13)|ovary(8)|upper_aerodigestive_tract(7)|large_intestine(6)|central_nervous_system(6)|skin(5)|NS(4)|prostate(4)|bone(4)|urinary_tract(3)|breast(3)|stomach(2)|haematopoietic_and_lymphoid_tissue(2)|liver(2)|oesophagus(2)|biliary_tract(1)|pancreas(1)											44	44	44			NA	NA	17		NA											NA				7578550		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	G	22.3	4.276306	0.80580	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000514944;ENST00000508793;ENST00000503591	D;D;D;D;D;D;D;D;D	0.99940	-8.39;-8.39;-8.39;-8.39;-8.39;-8.39;-8.39;-8.39;-8.39	5.48	4.51	0.55191	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.000000	0.85682	D	0.000000	D	0.99933	0.9970	M	0.91038	3.17	0.80722	D	1	D;D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	1.0;1.0;1.0;0.995;1.0;1.0;1.0	D	0.95614	0.8675	10	0.87932	D	0	-30.2503	12.2742	0.54724	0.0828:0.0:0.9172:0.0	.	88;127;127;34;127;127;127	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	Y	127;127;127;127;127;127;116;34;34;127;127	ENSP00000410739:S127Y;ENSP00000352610:S127Y;ENSP00000269305:S127Y;ENSP00000398846:S127Y;ENSP00000391127:S127Y;ENSP00000391478:S127Y;ENSP00000423862:S34Y;ENSP00000424104:S127Y;ENSP00000426252:S127Y	ENSP00000269305:S127Y	S	-	2	0	TP53	7519275	1.000000	0.71417	0.890000	0.34922	0.931000	0.56810	9.763000	0.98947	1.448000	0.47680	0.655000	0.94253	TCC	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	138.849525	KEEP		-	139.440385	0.420561	45	62	---	---	---	---	1	1	99	153	0	64	51	73	0	64	2	1	1	39	49	0	72	51	73	0	64	2	TP
THRA	7067	broad.mit.edu	37	17	38240101	38240101	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr17:38240101G>A	ENST00000450525.2	+	5	727	c.236G>A	c.(235-237)cGc>cAc	p.R79H	THRA_ENST00000394121.4_Missense_Mutation_p.R79H|THRA_ENST00000264637.4_Missense_Mutation_p.R79H|THRA_ENST00000546243.1_Missense_Mutation_p.R79H|THRA_ENST00000584985.1_Missense_Mutation_p.R79H	NM_199334.3	NP_955366.1	P10827	THA_HUMAN	thyroid hormone receptor, alpha	79		NA			negative regulation of RNA polymerase II transcriptional preinitiation complex assembly|negative regulation of transcription initiation, DNA-dependent|regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor|transcription from RNA polymerase II promoter	cytosol|nucleoplasm	protein domain specific binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity|steroid hormone receptor activity|TBP-class protein binding|thyroid hormone binding|thyroid hormone receptor activity|transcription regulatory region DNA binding|zinc ion binding	p.R79H(2)		endometrium(1)|kidney(3)|large_intestine(2)|lung(4)|prostate(1)	11	Colorectal(19;0.000442)	Myeloproliferative disorder(1115;0.0255)			Levothyroxine(DB00451)|Liothyronine(DB00279)	TTCTTTCGCCGCACAATCCAG	0.547		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		2	Substitution - Missense(2)	kidney(2)											145	129	134			NA	NA	17		NA											NA				38240101		2203	4300	6503	SO:0001583	missense			ENSG00000126351	HGNC:11796		Approved	uc002htw.3	NA	A8K3B5|P21205|Q8N6A1|Q96H73	ENST00000450525.2	37	CCDS42316.1	.	.	.	.	.	.	.	.	.	.	G	32	5.125665	0.94429	.	.	ENSG00000126351	ENST00000394121;ENST00000264637;ENST00000450525;ENST00000546243	D;D;D;D	0.98987	-5.3;-5.3;-5.3;-5.3	5.31	4.33	0.51752	Zinc finger, NHR/GATA-type (1);Zinc finger, nuclear hormone receptor-type (5);	0.000000	0.85682	D	0.000000	D	0.99625	0.9863	H	0.99475	4.585	0.80722	D	1	D;D;B	0.89917	1.0;1.0;0.007	D;D;B	0.97110	1.0;1.0;0.007	D	0.97246	0.9894	10	0.87932	D	0	.	14.0146	0.64517	0.0753:0.0:0.9247:0.0	.	79;79;79	P10827-3;P10827;Q6FH41	.;THA_HUMAN;.	H	79	ENSP00000377679:R79H;ENSP00000264637:R79H;ENSP00000395641:R79H;ENSP00000443972:R79H	ENSP00000264637:R79H	R	+	2	0	THRA	35493627	0.998000	0.40836	1.000000	0.80357	0.990000	0.78478	7.932000	0.87634	2.477000	0.83638	0.430000	0.28490	CGC	THRA-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257161.1	-45.798969	KEEP		+	7.842651	0.019324	4	203	---	---	---	---	1	0.9979175	3	951	0	246	4	252	0	246	2	0	0	0	0	0	0	4	252	0	246	2	TP
CDC6	990	broad.mit.edu	37	17	38450200	38450200	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr17:38450200A>T	ENST00000209728.4	+	6	1307		c.e6-1			NM_001254.3	NP_001245.1	Q99741	CDC6_HUMAN	cell division cycle 6	NA		NA			cell division|DNA replication|DNA replication checkpoint|M/G1 transition of mitotic cell cycle|mitosis|negative regulation of cell proliferation|negative regulation of DNA replication|positive regulation of cell cycle cytokinesis|positive regulation of chromosome segregation|regulation of cyclin-dependent protein kinase activity|regulation of mitotic anaphase|regulation of transcription involved in G1/S phase of mitotic cell cycle|S phase of mitotic cell cycle|traversing start control point of mitotic cell cycle	cytosol|nucleoplasm|spindle midzone|spindle pole	ATP binding|kinase binding|nucleoside-triphosphatase activity			breast(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(2)|lung(7)|ovary(2)|prostate(1)|stomach(2)|urinary_tract(1)	21						CTCTTTTTATAGTGTGTTGGT	0.408		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													248	214	225			NA	NA	17		NA											NA				38450200		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000094804	HGNC:1744		Approved	uc002huj.1	NA	Q8TB30	ENST00000209728.4	37	CCDS11365.1	.	.	.	.	.	.	.	.	.	.	A	24.4	4.523973	0.85600	.	.	ENSG00000094804	ENST00000209728	.	.	.	5.95	5.95	0.96441	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.4063	0.74881	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	CDC6	35703726	1.000000	0.71417	0.906000	0.35671	0.969000	0.65631	7.653000	0.83643	2.279000	0.76181	0.533000	0.62120	.	CDC6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257129.1	-115.083499	KEEP	Intron	+	6.696312	0.013304	6	445	---	---	---	---	1	0.03573351	73	3	3	286	7	533	3	286	4	0	0	0	0	0	0	7	533	3	286	2	TP
ANKFN1	162282	broad.mit.edu	37	17	54450005	54450005	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr17:54450005A>T	ENST00000566473.2	+	6	610		c.e6-1		ANKFN1_ENST00000318698.2_Splice_Site			Q8N957	ANKF1_HUMAN	ankyrin-repeat and fibronectin type III domain containing 1	NA		NA								NS(1)|breast(1)|cervix(2)|endometrium(4)|kidney(4)|large_intestine(11)|lung(27)|ovary(1)|prostate(1)|skin(1)	53						CTTTCCCTTTAGTTGTCAGCC	0.443		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													86	87	87			NA	NA	17		NA											NA				54450005		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000153930	HGNC:26766	NM_153228	Approved	uc002iun.1	NA		ENST00000566473.2	37		.	.	.	.	.	.	.	.	.	.	A	24.6	4.548753	0.86127	.	.	ENSG00000153930	ENST00000318698	.	.	.	5.64	5.64	0.86602	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.8687	0.79091	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	ANKFN1	51805004	1.000000	0.71417	0.950000	0.38849	0.981000	0.71138	9.339000	0.96797	2.146000	0.66826	0.379000	0.24179	.	ANKFN1-002	NOVEL	basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000435456.2	-56.380802	KEEP	Intron	+	8.787345	0.026616	7	256	---	---	---	---	1	0.03505847	10	0	0	136	8	299	0	136	2	0	0	0	0	0	0	8	299	0	136	2	TP
TAF4B	6875	broad.mit.edu	37	18	23937652	23937652	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr18:23937652A>T	ENST00000269142.5	+	14	3314		c.e14-1		TAF4B_ENST00000578121.1_Splice_Site	NM_005640.1	NP_005631.1	Q92750	TAF4B_HUMAN	TAF4b RNA polymerase II, TATA box binding protein (TBP)-associated factor, 105kDa	NA		NA			transcription elongation from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|viral reproduction	cytoplasm|nucleolus|transcription factor TFIID complex	DNA binding|NF-kappaB binding|sequence-specific DNA binding transcription factor activity			breast(1)|central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(7)|lung(13)|prostate(1)|skin(1)	29	all_cancers(21;0.00151)|Lung NSC(5;0.000401)|all_lung(6;0.00115)|Ovarian(20;0.124)		Epithelial(2;9.57e-07)|all cancers(3;5.15e-06)|OV - Ovarian serous cystadenocarcinoma(3;1.96e-05)|LUSC - Lung squamous cell carcinoma(2;0.00594)|Lung(2;0.0267)			TCCGTCTTCTAGTTACAGCAA	0.383		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													87	75	79			NA	NA	18		NA											NA				23937652		1841	4088	5929	SO:0001630	splice_region_variant				HGNC:11538	NM_005640	Approved	uc002kvu.4	NA	Q29YA4|Q29YA5	ENST00000269142.5	37	CCDS42421.1	.	.	.	.	.	.	.	.	.	.	A	16.08	3.020462	0.54576	.	.	ENSG00000141384	ENST00000418698;ENST00000269142	.	.	.	5.1	5.1	0.69264	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	13.4681	0.61268	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	TAF4B	22191650	1.000000	0.71417	0.999000	0.59377	0.677000	0.39632	4.889000	0.63171	1.905000	0.55150	0.523000	0.50628	.	TAF4B-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000446260.3	-26.15063	KEEP	Intron	+	7.780034	0.034722	5	139	---	---	---	---	1	0.02063313	5	0	0	81	7	166	0	81	2	0	0	0	0	0	0	7	166	0	81	2	TP
MAPRE2	10982	broad.mit.edu	37	18	32650157	32650157	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr18:32650157A>T	ENST00000436190.2	+	3	360		c.e3-1		MAPRE2_ENST00000538170.2_Intron|MAPRE2_ENST00000413393.1_Splice_Site|MAPRE2_ENST00000300249.5_Splice_Site|MAPRE2_ENST00000588910.1_Splice_Site|MAPRE2_ENST00000589699.1_Splice_Site	NM_001143827.2	NP_001137299.1	Q15555	MARE2_HUMAN	microtubule-associated protein, RP/EB family, member 2	NA		NA			cell division|cell proliferation|mitosis|signal transduction	cytoplasm|microtubule	microtubule binding			central_nervous_system(1)|endometrium(1)|large_intestine(3)|lung(3)|ovary(1)	9						TTTTTTTTCTAGTTGGGGAAT	0.383		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													133	124	127			NA	NA	18		NA											NA				32650157		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000166974	HGNC:6891	NM_014268	Approved	uc010xcc.3	NA	B2RE21|Q9UQ33	ENST00000436190.2	37	CCDS45850.1	.	.	.	.	.	.	.	.	.	.	A	23.5	4.420538	0.83559	.	.	ENSG00000166974	ENST00000436190;ENST00000300249	.	.	.	5.48	5.48	0.80851	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	15.5509	0.76152	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	MAPRE2	30904155	1.000000	0.71417	0.981000	0.43875	0.887000	0.51463	7.413000	0.80104	2.060000	0.61445	0.533000	0.62120	.	MAPRE2-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000442239.3	-36.108434	KEEP	Intron	+	8.669715	0.032086	6	181	---	---	---	---	1	0.9095286	167	6	0	166	6	238	0	166	2	0	0	0	0	0	0	6	238	0	166	2	TP
EEF2	1938	broad.mit.edu	37	19	3980665	3980665	+	Missense_Mutation	SNP	A	A	C			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr19:3980665A>C	ENST00000309311.6	-	9	1281	c.1193T>G	c.(1192-1194)aTt>aGt	p.I398S	EEF2_ENST00000600720.1_5'Flank|SNORD37_ENST00000384048.1_RNA	NM_001961.3	NP_001952.1	P13639	EF2_HUMAN	eukaryotic translation elongation factor 2	398		NA				cytosol|ribonucleoprotein complex	GTP binding|GTPase activity|protein binding|translation elongation factor activity			endometrium(4)|large_intestine(4)|lung(6)|ovary(1)|prostate(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	21		Hepatocellular(1079;0.137)		UCEC - Uterine corpus endometrioid carcinoma (162;6.64e-05)|BRCA - Breast invasive adenocarcinoma(158;0.00461)|GBM - Glioblastoma multiforme(1328;0.0223)|STAD - Stomach adenocarcinoma(1328;0.18)		CATTTTGGAAATATACATCAT	0.527		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(165;1804 1908 4071 6587 18799)							NA		NA		0													82	82	82			NA	NA	19		NA											NA				3980665		2203	4300	6503	SO:0001583	missense			ENSG00000167658	HGNC:3214	NM_001961	Approved	uc002lze.3	NA	B2RMP5|D6W618|Q58J86	ENST00000309311.6	37	CCDS12117.1	.	.	.	.	.	.	.	.	.	.	A	27.7	4.852893	0.91355	.	.	ENSG00000167658	ENST00000543343;ENST00000309311	D	0.83250	-1.7	5.66	5.66	0.87406	Translation elongation/initiation factor/Ribosomal, beta-barrel (1);	0.000000	0.85682	D	0.000000	D	0.88658	0.6496	M	0.93808	3.46	0.80722	D	1	D	0.54397	0.966	P	0.44860	0.462	D	0.91652	0.5335	10	0.87932	D	0	-24.1334	15.0645	0.71983	1.0:0.0:0.0:0.0	.	398	P13639	EF2_HUMAN	S	398	ENSP00000307940:I398S	ENSP00000307940:I398S	I	-	2	0	EEF2	3931665	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	9.283000	0.95860	2.159000	0.67721	0.459000	0.35465	ATT	EEF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000457615.2	48.233536	KEEP		-	49.804005	0.304348	14	32	---	---	---	---	1	1	1739	3932	0	82	15	43	0	82	2	0	0	0	0	0	0	15	43	0	82	2	TP
SYMPK	8189	broad.mit.edu	37	19	46324560	46324560	+	Intron	SNP	C	C	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr19:46324560C>A	ENST00000245934.7	-	22	3138				SYMPK_ENST00000598155.1_Intron	NM_004819.2	NP_004810.2	Q92797	SYMPK_HUMAN	symplekin	NA		NA			cell adhesion|mRNA processing	cytoplasm|cytoskeleton|nucleoplasm|tight junction	protein binding			breast(3)|central_nervous_system(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(7)|liver(1)|lung(25)|ovary(1)|urinary_tract(1)	45		all_neural(266;0.0299)|Ovarian(192;0.0308)		OV - Ovarian serous cystadenocarcinoma(262;0.00509)|GBM - Glioblastoma multiforme(486;0.0593)		TTGGCAGATTCCAGTGGGGGC	0.612		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													NA	NA	NA			NA	NA			NA											NA				NA		NA	NA	NA	SO:0001627	intron_variant			ENSG00000125755	HGNC:22935	NM_004819	Approved	uc002pdn.3	NA	O00521|O00689|O00733|Q59GT5|Q8N2U5	ENST00000245934.7	37	CCDS12676.2																																																																																			SYMPK-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000316581.1	15.84296	KEEP		-	16.286291	0.333333	6	12	---	---	---	---	1	1	8	259	0	33	6	13	0	33	2	0	0	0	0	0	0	6	13	0	33	2	TP
TTC3	7267	broad.mit.edu	37	21	38504980	38504980	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr21:38504980A>T	ENST00000399017.2	+	17	4105		c.e17-1		TTC3_ENST00000479930.1_Splice_Site|TTC3_ENST00000355666.1_Splice_Site|TTC3_ENST00000354749.2_Splice_Site|TTC3_ENST00000540756.1_Splice_Site	NM_003316.3	NP_003307.3	P53804	TTC3_HUMAN	tetratricopeptide repeat domain 3	NA		NA			protein K48-linked ubiquitination|ubiquitin-dependent protein catabolic process	nucleus	protein binding|ubiquitin-protein ligase activity|zinc ion binding			breast(5)|endometrium(7)|kidney(5)|large_intestine(17)|liver(1)|lung(18)|ovary(4)|prostate(2)|skin(9)|upper_aerodigestive_tract(2)|urinary_tract(5)	75		Myeloproliferative disorder(46;0.0412)				TTTTTCTTTTAGTTCTAGTTC	0.348		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Ovarian(38;194 1649 35661)							NA		NA		0													37	38	38			NA	NA	21		NA											NA				38504980		2202	4298	6500	SO:0001630	splice_region_variant			ENSG00000182670	HGNC:12393		Approved	uc002yvz.3	NA	A8K7H7|B2RPA7|D3DSG9|D3DSH2|D3DSH3|O60767|P78476|P78477|Q569I2|Q6P578|Q9UEK4	ENST00000399017.2	37	CCDS13651.1	.	.	.	.	.	.	.	.	.	.	A	16.74	3.207696	0.58343	.	.	ENSG00000182670	ENST00000418766;ENST00000450533;ENST00000438055;ENST00000355666;ENST00000540756;ENST00000399017;ENST00000354749	.	.	.	5.35	5.35	0.76521	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.9958	0.53201	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	TTC3	37426850	0.767000	0.28508	0.656000	0.29637	0.946000	0.59487	4.058000	0.57463	2.133000	0.65898	0.528000	0.53228	.	TTC3-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000194776.1	0.131761	KEEP	Intron	+	9.160236	0.092593	5	49	---	---	---	---	1	0.8479698	38	3	0	110	5	56	0	110	2	0	0	0	0	0	0	5	56	0	110	2	TP
EP300	2033	broad.mit.edu	37	22	41566408	41566408	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chr22:41566408A>T	ENST00000263253.7	+	27	5505		c.e27-1		RNU6-375P_ENST00000517050.1_RNA|RP1-85F18.6_ENST00000415054.1_RNA	NM_001429.3	NP_001420.2	Q09472	EP300_HUMAN	E1A binding protein p300	NA		NA			apoptosis|cell cycle|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|histone H4 acetylation|interspecies interaction between organisms|N-terminal peptidyl-lysine acetylation|positive regulation of sequence-specific DNA binding transcription factor activity|positive regulation of transcription from RNA polymerase II promoter|regulation of androgen receptor signaling pathway|response to estrogen stimulus|response to hypoxia	centrosome|histone acetyltransferase complex	androgen receptor binding|beta-catenin binding|DNA binding|histone acetyltransferase activity|RNA polymerase II activating transcription factor binding|transcription coactivator activity|zinc ion binding			NS(2)|breast(11)|central_nervous_system(7)|cervix(1)|endometrium(10)|haematopoietic_and_lymphoid_tissue(31)|kidney(5)|large_intestine(31)|liver(2)|lung(33)|ovary(2)|pancreas(4)|prostate(1)|skin(6)|stomach(1)|upper_aerodigestive_tract(8)|urinary_tract(16)	171						TTGTATTGTTAGTTACACAAC	0.383		NA	"""T,  N, F, Mis, O"""	"""MLL, RUNXBP2"""	"""colorectal, breast, pancreatic, AML, ALL, DLBCL"""		NA		Rubinstein-Taybi syndrome					NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Rec	yes		22	22q13	2033	300 kd E1A-Binding protein gene	NA	"""L, E"""	0													109	99	102			NA	NA	22		NA											NA				41566408		2203	4300	6503	SO:0001630	splice_region_variant	Familial Cancer Database	Broad Thumb-Hallux syndrome	ENSG00000100393	HGNC:3373	NM_001429	Approved	uc003azl.4	NA	B1AKC2	ENST00000263253.7	37	CCDS14010.1	.	.	.	.	.	.	.	.	.	.	A	20.2	3.946030	0.73672	.	.	ENSG00000100393	ENST00000263253	.	.	.	4.86	4.86	0.63082	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	11.2125	0.48806	0.8466:0.1534:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	EP300	39896354	1.000000	0.71417	0.662000	0.29724	0.510000	0.34073	9.237000	0.95368	2.121000	0.65114	0.533000	0.62120	.	EP300-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000320600.1	-39.97809	KEEP	Intron	+	6.892259	0.026455	5	184	---	---	---	---	1	0.4299382	57	1	0	152	5	227	0	152	2	0	0	0	0	0	0	5	227	0	152	2	TP
PRPS2	5634	broad.mit.edu	37	X	12828240	12828240	+	Missense_Mutation	SNP	T	T	A			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chrX:12828240T>A	ENST00000380668.5	+	4	633	c.505T>A	c.(505-507)Tca>Aca	p.S169T	PRPS2_ENST00000489404.1_Missense_Mutation_p.S169T|PRPS2_ENST00000398491.2_Missense_Mutation_p.S172T	NM_001039091.2|NM_002765.4	NP_001034180.1|NP_002756.1	P11908	PRPS2_HUMAN	phosphoribosyl pyrophosphate synthetase 2	169		NA			nucleoside metabolic process|ribonucleoside monophosphate biosynthetic process		ATP binding|kinase activity|magnesium ion binding|protein homodimerization activity|ribose phosphate diphosphokinase activity			breast(1)|cervix(1)|endometrium(3)|kidney(2)|large_intestine(3)|lung(5)|urinary_tract(1)	16						TATCATTGTTTCACCTGACGC	0.463		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													111	95	101			NA	NA	X		NA											NA				12828240		2203	4300	6503	SO:0001583	missense			ENSG00000101911	HGNC:9465	NM_002765	Approved	uc004cva.3	NA	Q0VDH9|Q0VDI0|Q15245|Q2TAK7	ENST00000380668.5	37	CCDS14150.1	.	.	.	.	.	.	.	.	.	.	T	13.62	2.290454	0.40494	.	.	ENSG00000101911	ENST00000380668;ENST00000398491;ENST00000489404;ENST00000461630;ENST00000460220	D;D;D;T	0.96651	-3.12;-3.12;-4.08;-0.76	4.91	4.91	0.64330	Phosphoribosyltransferase (1);	0.000000	0.85682	D	0.000000	D	0.97804	0.9279	H	0.94771	3.58	0.80722	D	1	P;P	0.41366	0.747;0.703	P;B	0.48368	0.575;0.439	D	0.98715	1.0706	10	0.87932	D	0	-10.9179	14.0079	0.64475	0.0:0.0:0.0:1.0	.	169;172	P11908;P11908-2	PRPS2_HUMAN;.	T	169;172;169;82;59	ENSP00000370043:S169T;ENSP00000381504:S172T;ENSP00000419380:S169T;ENSP00000418911:S82T	ENSP00000370043:S169T	S	+	1	0	PRPS2	12738161	1.000000	0.71417	0.733000	0.30861	0.366000	0.29705	7.538000	0.82048	1.754000	0.51921	0.483000	0.47432	TCA	PRPS2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000055772.2	399.023261	KEEP		+	416.302528	0.861314	118	19	---	---	---	---	1	1	80	3	0	114	164	27	0	114	2	0	0	0	0	0	0	164	27	0	114	2	TP
EIF2S3	1968	broad.mit.edu	37	X	24084113	24084113	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chrX:24084113A>T	ENST00000253039.4	+	8	1025		c.e8-1			NM_001415.3	NP_001406.1	P41091	IF2G_HUMAN	eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa	NA		NA				cytosol	GTP binding|GTPase activity|protein binding|translation initiation factor activity			breast(1)|cervix(1)|endometrium(4)|large_intestine(1)|lung(4)|ovary(1)	12						GTTTTATTTTAGTTATTAGAT	0.303		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													111	108	109			NA	NA	X		NA											NA				24084113		2203	4299	6502	SO:0001630	splice_region_variant			ENSG00000130741	HGNC:3267	NM_001415	Approved	uc004dbc.3	NA	B5BTZ4	ENST00000253039.4	37	CCDS14210.1	.	.	.	.	.	.	.	.	.	.	N	21.4	4.143064	0.77888	.	.	ENSG00000130741	ENST00000253039	.	.	.	5.49	5.49	0.81192	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	14.804	0.69938	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	EIF2S3	23994034	1.000000	0.71417	1.000000	0.80357	0.916000	0.54674	8.840000	0.92125	1.946000	0.56461	0.438000	0.28831	.	EIF2S3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000056079.1	-9.669486	KEEP	Intron	+	7.242275	0.050633	4	75	---	---	---	---	1	0.003289474	2	0	0	135	4	89	0	135	2	0	0	0	0	0	0	4	89	0	135	2	TP
MSN	4478	broad.mit.edu	37	X	64949532	64949532	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chrX:64949532A>G	ENST00000360270.5	+	4	597	c.425A>G	c.(424-426)cAt>cGt	p.H142R		NM_002444.2	NP_002435.1	P26038	MOES_HUMAN	moesin	142	FERM.	NA			leukocyte cell-cell adhesion|leukocyte migration|membrane to membrane docking	apical plasma membrane|cytoskeleton|extrinsic to membrane|microvillus membrane|nucleolus	cell adhesion molecule binding|receptor binding|structural constituent of cytoskeleton		MSN/ALK(6)	breast(4)|central_nervous_system(3)|endometrium(7)|kidney(5)|large_intestine(6)|lung(11)|ovary(3)|prostate(1)|skin(2)|urinary_tract(1)	43						AAGGAAGTGCATAAGTCTGGC	0.562		NA	T	ALK	ALCL		NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		X	Xq11.2-q12	4478	moesin	NA	L	0													65	46	53			NA	NA	X		NA											NA				64949532		2203	4300	6503	SO:0001583	missense			ENSG00000147065	HGNC:7373	NM_002444	Approved	uc004dwf.3	NA		ENST00000360270.5	37	CCDS14382.1	.	.	.	.	.	.	.	.	.	.	A	17.85	3.489285	0.64074	.	.	ENSG00000147065	ENST00000360270	D	0.84223	-1.82	5.85	5.85	0.93711	Band 4.1 domain (1);FERM central domain (2);FERM domain (1);FERM/acyl-CoA-binding protein, 3-helical bundle (1);	0.086699	0.85682	D	0.000000	D	0.92779	0.7704	H	0.95780	3.72	0.80722	D	1	B	0.23316	0.083	B	0.42522	0.39	D	0.92124	0.5706	10	0.72032	D	0.01	.	13.964	0.64199	1.0:0.0:0.0:0.0	.	142	P26038	MOES_HUMAN	R	142	ENSP00000353408:H142R	ENSP00000353408:H142R	H	+	2	0	MSN	64866257	1.000000	0.71417	1.000000	0.80357	0.831000	0.47069	9.237000	0.95368	1.984000	0.57885	0.430000	0.28490	CAT	MSN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000056981.1	231.343755	KEEP		+	243.306053	0.924242	61	5	---	---	---	---	1	1	268	133	1	43	72	6	1	43	27	0	0	0	0	0	0	72	6	1	43	2	TP
FAM122C	159091	broad.mit.edu	37	X	133948799	133948799	+	Splice_Site	SNP	A	A	T			GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-02-2485-Tumor-SM-16YAB	GBM-TCGA-02-2485-Normal-SM-1QXMH	g.chrX:133948799A>T	ENST00000445123.1	+	3	274		c.e3-1		FAM122C_ENST00000414371.2_Splice_Site|FAM122C_ENST00000370785.3_Splice_Site|FAM122C_ENST00000370784.4_Splice_Site			Q6P4D5	F222C_HUMAN	family with sequence similarity 122C	NA		NA								endometrium(2)|kidney(1)|lung(2)	5	Acute lymphoblastic leukemia(192;0.000127)					TTTTCTTTTTAGTTTTAATTC	0.338		NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0													60	60	60			NA	NA	X		NA											NA				133948799		2202	4300	6502	SO:0001630	splice_region_variant			ENSG00000156500	HGNC:25202	NM_138819	Approved	uc004exz.2	NA	Q8WVK9	ENST00000445123.1	37		.	.	.	.	.	.	.	.	.	.	a	10.31	1.313542	0.23908	.	.	ENSG00000156500	ENST00000414371;ENST00000370784;ENST00000370785	.	.	.	5.33	5.33	0.75918	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	10.7226	0.46048	1.0:0.0:0.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	FAM122C	133776465	1.000000	0.71417	0.663000	0.29738	0.151000	0.21798	4.668000	0.61568	1.800000	0.52685	0.466000	0.42574	.	FAM122C-203	KNOWN	basic	protein_coding	NA	protein_coding		-3.953301	KEEP	Intron	+	14.065189	0.072917	7	89	---	---	---	---	1	0.2170551	11	0	0	115	8	104	0	115	2	0	0	0	0	0	0	8	104	0	115	2	TP
